<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Front Neurol</journal-id><journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id><journal-title-group><journal-title>Frontiers in Neurology</journal-title></journal-title-group><issn pub-type="epub">1664-2295</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5758544</article-id><article-id pub-id-type="doi">10.3389/fneur.2017.00723</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Clinical Trial</subject></subj-group></subj-group></article-categories><title-group><article-title>Action Observation Plus Sonification. A Novel Therapeutic Protocol for Parkinson&#x02019;s Patient with Freezing of Gait</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mezzarobba</surname><given-names>Susanna</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/489577"/></contrib><contrib contrib-type="author"><name><surname>Grassi</surname><given-names>Michele</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pellegrini</surname><given-names>Lorella</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Catalan</surname><given-names>Mauro</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kruger</surname><given-names>Bjorn</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/326576"/></contrib><contrib contrib-type="author"><name><surname>Furlanis</surname><given-names>Giovanni</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Manganotti</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bernardis</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/451324"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Life Sciences, University of Trieste</institution>, <addr-line>Trieste</addr-line>, <country>Italy</country></aff><aff id="aff2"><sup>2</sup><institution>Azienda Sanitaria Universitaria Integrata di Trieste</institution>, <addr-line>Trieste</addr-line>, <country>Italy</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Medical, Surgical and Health Sciences, University of Trieste</institution>, <addr-line>Trieste</addr-line>, <country>Italy</country></aff><aff id="aff4"><sup>4</sup><institution>Gokhale Method Institute</institution>, <addr-line>Palo Alto, CA</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Diego Minciacchi, University of Florence, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Matthew Rodger, Queen&#x02019;s University Belfast, United Kingdom; Elisa Pelosin, University of Genoa, Italy</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Susanna Mezzarobba, <email>mezzarob@units.it</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Neuroprosthetics, a section of the journal Frontiers in Neurology</p></fn></author-notes><pub-date pub-type="epub"><day>04</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><elocation-id>723</elocation-id><history><date date-type="received"><day>20</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>13</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Mezzarobba, Grassi, Pellegrini, Catalan, Kruger, Furlanis, Manganotti and Bernardis.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Mezzarobba, Grassi, Pellegrini, Catalan, Kruger, Furlanis, Manganotti and Bernardis</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Freezing of gait (FoG) is a disabling symptom associated with falls, with little or no responsiveness to pharmacological treatment. Current protocols used for rehabilitation are based on the use of external sensory cues. However, cued strategies might generate an important dependence on the environment. Teaching motor strategies without cues [i.e., action observation (AO) plus Sonification] could represent an alternative/innovative approach to rehabilitation that matters most on appropriate allocation of attention and lightening cognitive load. We aimed to test the effects of a novel experimental protocol to treat patients with Parkinson&#x02019;s disease (PD) and FoG, using functional, and clinical scales. The experimental protocol was based on AO plus Sonification. 12 patients were treated with 8 motor gestures. They watched eight videos showing an actor performing the same eight gestures, and then tried to repeat each gesture. Each video was composed by images and sounds of the gestures. By means of the Sonification technique, the sounds of gestures were obtained by transforming kinematic data (velocity) recorded during gesture execution, into pitch variations. The same 8 motor gestures were also used in a second group of 10 patients; which were treated with a standard protocol based on a common sensory stimulation method. All patients were tested with functional and clinical scales before, after, at 1&#x02009;month, and 3&#x02009;months after the treatment. Data showed that the experimental protocol have positive effects on functional and clinical tests. In comparison with the baseline evaluations, significant performance improvements were seen in the NFOG questionnaire, and the UPDRS (parts II and III). Importantly, all these improvements were consistently observed at the end, 1&#x02009;month, and 3&#x02009;months after treatment. No improvement effects were found in the group of patients treated with the standard protocol. These data suggest that a multisensory approach based on AO plus Sonification, with the two stimuli semantically related, could help PD patients with FoG to relearn gait movements, to reduce freezing episodes, and that these effects could be prolonged over time.</p></abstract><kwd-group><kwd>freezing of gait</kwd><kwd>action observation</kwd><kwd>Sonification</kwd><kwd>Parkinson&#x02019;s disease</kwd><kwd>cueing</kwd></kwd-group><counts><fig-count count="4"/><table-count count="4"/><equation-count count="1"/><ref-count count="64"/><page-count count="13"/><word-count count="9354"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>For decades, motor and gait difficulties have been identified as the main symptoms of Parkinson&#x02019;s disease (PD), and drug therapy&#x02014;based on dopamine and its agonists&#x02014;was considered the only feasible solution to ameliorate symptoms. Amid these motor symptoms and gait abnormalities, freezing of gait (FoG) is the most debilitating; a sudden episodic inability to generate an effective stepping, which commonly, leads to falls.</p><p>However, PD is a complex neurological disease that comprises also severe psychiatric and cognitive symptoms. Today, the benchmark to treat PD symptoms, especially when they worsen, is the use of specific rehabilitation protocols together with medication and/or surgical therapy.</p><p>Drug therapy in PD is a symptomatic therapy, primarily aimed at restoring dopaminergic function in the striatum. Although irreplaceable in the treatment of PD symptoms, several data demonstrate also negative effects, produced by dopamine on certain movements, and cognitive functions. Indeed, while dopaminergic medication clearly enhances certain motor functions, at the same time might negatively affect the learning of movement sequences (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>), as well as specific cognitive functions (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). Moreover, the absent or controversial pharmacological responsiveness of FoG has led to an increasing interest in rehabilitation interventions aimed at functional recovery and autonomy, by relearning a physiological gait pattern.</p><p>Currently, protocols employed for rehabilitation of PD&#x02014;with and without FoG&#x02014;are based on the use of external sensory cues&#x02014;mainly visual, but also auditory and tactile&#x02014;because it allows the switch from <italic>automatic</italic> movement (habitual)&#x02014;controlled by frontostriatal pathways, that PD patients have compromised&#x02014;to <italic>voluntary controlled</italic> movement [goal directed (<xref rid="B5" ref-type="bibr">5</xref>)]. Specifically, Vandenbossche et al. (<xref rid="B6" ref-type="bibr">6</xref>) showed that PD patients with FoG exhibit a specific impairment in the acquisition of automaticity&#x02014;correlated with the working memory functions&#x02014;and suggested that therapies should focus on training that reduce working memory load, as the cued strategies.</p><p>During exposure to visual and auditory cues, patients with FoG, as those without, improve gait kinematics and reduce freezing. Interestingly, visual cues have more powerful effects than auditory cues for reducing FoG (<xref rid="B7" ref-type="bibr">7</xref>); proving that the inability to maintain effective scaling of step amplitude could be an important FOG-related deficit. Conversely, auditory cues (metronome) seem to be less effective in the regularization of altered cadence, and disordered coordination of inter-limb movement in patients with FoG. Unfortunately, it has been shown that cueing might generate an important dependence on the environment, particularly the visual ones, considering how important is the exploration of the whole visual field in intentional walk (<xref rid="B8" ref-type="bibr">8</xref>).</p><p>In the last years, several researchers try to use cues differently. Young et al. (<xref rid="B9" ref-type="bibr">9</xref>) asked Parkinson&#x02019;s patients with and without FoG to listen to different auditory cues (i.e., a metronome or ecological footsteps sounds recorded on gravel), and to step in place to each cue, synchronizing their own stepping in time to the sound. Results in patients with FoG showed remarkable improvements in temporal regularity. The authors claim that in PD patients with FoG, the mechanism &#x0201c;action imitation enhances the motor performance&#x0201d; is supported by their results with action-relevant cues (i.e., footsteps recorded on gravel).</p><p>Teaching <italic>motor strategies</italic>, without cues to overcome or avoid freezing episodes can be an alternative/innovative approach to rehabilitation, that matters most on appropriate allocation of attention (<xref rid="B10" ref-type="bibr">10</xref>), and lightening cognitive load. One of these strategies&#x02014;action observation (AO)&#x02014;is based on the activation/sharing of a common neural substrate, the mirror system (<xref rid="B11" ref-type="bibr">11</xref>). The <italic>priming effect</italic> of AO on subsequent motor execution of the observed gesture is well known in neurorehabilitation, although few evidences are available for treatment of patients of PD (<xref rid="B12" ref-type="bibr">12</xref>).</p><p>Furthermore, one way to reduce cognitive load in the recovery/learning of motor gestures is the use of multisensory approaches that enhance perceptual processes (<xref rid="B13" ref-type="bibr">13</xref>), which are known to be reduced in PD patients with FoG (<xref rid="B14" ref-type="bibr">14</xref>). The use of multisensory stimuli improves the learning process (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B15" ref-type="bibr">15</xref>) thanks to a reduced cognitive load, and to an easier storage in short-term memory (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). But, to exert the most efficient facilitatory effect, pairs of stimuli composing the multisensory stimulus should be congruent, and not simply concomitant in space and/or time (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>). These findings have stimulated interest toward the use of audiovisual stimuli to facilitate relearning of movements also in the field of neurological rehabilitation.</p><p>Evidence on the efficacy of action-related <italic>sonified</italic> sounds (synthetized sounds obtained with a <italic>Sonification</italic> procedure, see the next paragraph) to improve motor performance is well documented [for a review, see Ref. (<xref rid="B20" ref-type="bibr">20</xref>)], although in PD patients is still limited. Indeed, Rodger et al. (<xref rid="B21" ref-type="bibr">21</xref>) used two different types of sounds (ecological and synthetized) to help guide and improve walking actions of PD patients. One of these techniques was based on Sonification of the ground reaction forces. Both methods showed that PD patients could use rich auditory representations of action to guide and improve the quality of walking, and reducing the risk of falls and injury. Moreover, Schmitz et al. (<xref rid="B17" ref-type="bibr">17</xref>) demonstrated that the Sonification of movements enhance the activity in the human AO system including subcortical structures of the motor loop; and therefore, may be an important method to enhance therapy effects in neurological rehabilitation.</p><p>The most natural way to use audio&#x02013;video stimuli is to present images together with <italic>ecological</italic> sounds (i.e., a walker and the sound of his/her feet). Instead of utilizing the real sounds produced during gait, we employed synthetized sounds obtained with the Sonification technique (<xref rid="B22" ref-type="bibr">22</xref>). Specifically, in our audiovisual stimuli, the auditory component is obtained by transforming kinematic data of relevant body part movements&#x02014;visible in the video&#x02014;into sounds. This process is called <italic>Sonification</italic>. We choose to use sonified sounds&#x02014;in place of real sounds (i.e., footsteps sound)&#x02014;because in this way we can convey additional information, important for the understanding and reproduction of a correct movement (i.e., differences in the velocity of the hips rotation during gait), that otherwise will be ignored. This final stimulus is a sort of <italic>augmented</italic> audio&#x02013;video stimulus. The processing of auditory and visual information together facilitates the recognition of the movement in its spatial and temporal aspects, and the relearning process of the correct pattern of movements. These stimuli could be of particular importance for PD patients with FoG in which these components are altered, and in which, probably, visuo-perceptive modifications may be present (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>We hypothesized that AO can be used to facilitate recovery of defective motor control, and given that PD patients with FoG may have major shortages of attention resources, a multisensory approach (i.e., audiovisual stimuli) would help to further reduce the attention load, facilitating learning processes.</p><p>The aim of this study was to test the efficacy of a novel protocol based on AO technique and Sonification, and to compare the effect with a standard protocol based on external sensory cues. With this purpose, we designed and realized an experimental study to test the effectiveness of these two protocols in two groups of PD patients with FoG. We hypothesized that gait improvement of the AO plus Sonification protocol would be better than those obtained with the standard protocol, both in the short term and the long term (3-month follow-up).</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><sec id="S2-1"><title>Design</title><p>The whole pilot RCT was carried out from April 2015 to December 2016. Post-intervention measures were collected at the end, 1&#x02009;month, and 3&#x02009;months after the end of the treatment. Patients were randomly assigned to two different training group (experimental and control groups). An investigator, neither involved in the treatment protocol nor in the selection and evaluation of patients, created the computerized randomization procedure (blocked randomization). The same investigator concealed treatment allocation by using small opaque envelopes. Three trained physical therapists with a solid experience in the treatment of PD were involved in the evaluation&#x02014;one of them&#x02014;and in the treatment of patients&#x02014;the other two. Outcome measures were videotaped and also evaluated by a second independent rater blind to the whole experimental study. In case of discrepancies between the two, a third blind rater was used to resolve the evaluation.</p><p>Patients were advised to have their medical treatment continued unchanged throughout the study. This study was carried out in accordance with the recommendations of the &#x0201c;Comitato Etico Regionale Unico&#x0201d; guidelines, with written informed consent from all subjects. All subjects gave written informed consent in accordance with the Declaration of Helsinki. The protocol was approved by the Institutional Ethics Committee (Comitato Etico Regionale Unico&#x02014;Friuli Venezia Giulia. Protocol no. 4456&#x02014;05.02.2015). Patients who agreed to participate always signed a written informed consent and they were able to leave the experiment at any moment, with no additional explanations. The study has been registered at <uri xlink:type="simple" xlink:href="http://Clinicaltrials.gov">http://Clinicaltrials.gov</uri>, NCT03249155.</p></sec><sec id="S2-2"><title>Participants</title><p>Thirty-seven patients with idiopathic PD (see Figure <xref ref-type="fig" rid="F1">1</xref>), according UK Brain Bank (<xref rid="B23" ref-type="bibr">23</xref>) were assessed by a neurologist expert in movement disorders, from the outpatient Neurological Clinic, Cattinara Hospital. Eligibility criteria were occurrence of FoG (<xref rid="B24" ref-type="bibr">24</xref>) based on patient&#x02019;s verbal account of his/her freezing experience (or recognition of their typical FoG experience when this symptom was described to him/her by a physician); stages 1&#x02013;3 on the Hoehn and Yahr scale (<xref rid="B25" ref-type="bibr">25</xref>); stable medication regimen for at least 8&#x02009;weeks; no major depressive symptoms as defined by a Beck Depression Inventory score &#x02264;16 [BDI (<xref rid="B26" ref-type="bibr">26</xref>)]; no signs of dementia as defined by a Mini-Mental Status Examination score &#x0003e;24 [MMSE (<xref rid="B27" ref-type="bibr">27</xref>)]. The exclusion criteria were evidence of any adjunctive orthopedic comorbidities that make it impossible to use physical activities and an independent locomotion; others neurological and psychiatric disease; presence of any implanted stimulating or pacing device in central nervous system. Prior power analysis estimated a sample size group of 10 participants. After the first assessment, we enrolled a total of 24 patients (see Figure <xref ref-type="fig" rid="F1">1</xref>). Two subjects dropped out due to concurrent, unrelated medical events: thus, 22 patients completed the study (see Table <xref ref-type="table" rid="T1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Flowchart showing the structure of the study, enrollment and evaluation procedure, and how the patients were divided into the groups, and phases.</p></caption><graphic xlink:href="fneur-08-00723-g001"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic and clinical characteristics of patients with Parkinson&#x02019;s disease at baseline.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">AOS group (<italic>n</italic>&#x02009;=&#x02009;12)</th><th valign="top" align="center" rowspan="1" colspan="1">Cue group (<italic>n</italic>&#x02009;=&#x02009;10)</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="3" rowspan="1"><bold>Patients&#x02019; characteristics</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender female/male (% female)</td><td align="center" valign="top" rowspan="1" colspan="1">5/7 (42%)</td><td align="center" valign="top" rowspan="1" colspan="1">3/7 (30%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="top" rowspan="1" colspan="1">74.67&#x02009;&#x000b1;&#x02009;5.93</td><td align="center" valign="top" rowspan="1" colspan="1">72&#x02009;&#x000b1;&#x02009;5.87</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration (years)</td><td align="center" valign="top" rowspan="1" colspan="1">10.75&#x02009;&#x000b1;&#x02009;3.44</td><td align="center" valign="top" rowspan="1" colspan="1">9.4&#x02009;&#x000b1;&#x02009;4.86</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mini-Mental State Exam</td><td align="center" valign="top" rowspan="1" colspan="1">27.46&#x02009;&#x000b1;&#x02009;1.81</td><td align="center" valign="top" rowspan="1" colspan="1">26.58&#x02009;&#x000b1;&#x02009;1.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Beck Depression Inventory</td><td align="center" valign="top" rowspan="1" colspan="1">8&#x02009;&#x000b1;&#x02009;5.98</td><td align="center" valign="top" rowspan="1" colspan="1">6.4&#x02009;&#x000b1;&#x02009;5.93</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hoehn and Yahr stage</td><td align="center" valign="top" rowspan="1" colspan="1">2.33&#x02009;&#x000b1;&#x02009;0.49</td><td align="center" valign="top" rowspan="1" colspan="1">2.3&#x02009;&#x000b1;&#x02009;0.67</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Levodopa equivalent</td><td align="center" valign="top" rowspan="1" colspan="1">972.5&#x02009;&#x000b1;&#x02009;253.17</td><td align="center" valign="top" rowspan="1" colspan="1">983.22&#x02009;&#x000b1;&#x02009;379.58</td></tr><tr><td align="left" valign="top" colspan="3" rowspan="1"><bold>Primary outcome measure</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NFOGQ</td><td align="center" valign="top" rowspan="1" colspan="1">18.17&#x02009;&#x000b1;&#x02009;4.61</td><td align="center" valign="top" rowspan="1" colspan="1">16.6&#x02009;&#x000b1;&#x02009;7.86</td></tr><tr><td align="left" valign="top" colspan="3" rowspan="1"><bold>Secondary outcome measures</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UPDRS II Total</td><td align="center" valign="top" rowspan="1" colspan="1">16.42&#x02009;&#x000b1;&#x02009;5.99</td><td align="center" valign="top" rowspan="1" colspan="1">17.1&#x02009;&#x000b1;&#x02009;6.47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UPDRS III Total</td><td align="center" valign="top" rowspan="1" colspan="1">32.92&#x02009;&#x000b1;&#x02009;8.69</td><td align="center" valign="top" rowspan="1" colspan="1">33.2&#x02009;&#x000b1;&#x02009;13.99</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MPAS</td><td align="center" valign="top" rowspan="1" colspan="1">53.75&#x02009;&#x000b1;&#x02009;6.27</td><td align="center" valign="top" rowspan="1" colspan="1">50.2&#x02009;&#x000b1;&#x02009;9.22</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BBS</td><td align="center" valign="top" rowspan="1" colspan="1">47.75&#x02009;&#x000b1;&#x02009;4.16</td><td align="center" valign="top" rowspan="1" colspan="1">47.8&#x02009;&#x000b1;&#x02009;3.46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6MWT (s)</td><td align="center" valign="top" rowspan="1" colspan="1">280.75&#x02009;&#x000b1;&#x02009;93.34</td><td align="center" valign="top" rowspan="1" colspan="1">296.75&#x02009;&#x000b1;&#x02009;48.32</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TUG (ms)</td><td align="center" valign="top" rowspan="1" colspan="1">1,299.75&#x02009;&#x000b1;&#x02009;376.74</td><td align="center" valign="top" rowspan="1" colspan="1">1,271.3&#x02009;&#x000b1;&#x02009;615.86</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 mobility</td><td align="center" valign="top" rowspan="1" colspan="1">49.38&#x02009;&#x000b1;&#x02009;22.54</td><td align="center" valign="top" rowspan="1" colspan="1">35.5&#x02009;&#x000b1;&#x02009;25.87</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 activities of daily living</td><td align="center" valign="top" rowspan="1" colspan="1">33.4&#x02009;&#x000b1;&#x02009;21.99</td><td align="center" valign="top" rowspan="1" colspan="1">28.75&#x02009;&#x000b1;&#x02009;17.84</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 emotional well-being</td><td align="center" valign="top" rowspan="1" colspan="1">23.82&#x02009;&#x000b1;&#x02009;21.84</td><td align="center" valign="top" rowspan="1" colspan="1">33.33&#x02009;&#x000b1;&#x02009;20.13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 stigma</td><td align="center" valign="top" rowspan="1" colspan="1">21.04&#x02009;&#x000b1;&#x02009;22.94</td><td align="center" valign="top" rowspan="1" colspan="1">18.75&#x02009;&#x000b1;&#x02009;20.41</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 social support</td><td align="center" valign="top" rowspan="1" colspan="1">2.78&#x02009;&#x000b1;&#x02009;6.49</td><td align="center" valign="top" rowspan="1" colspan="1">15.83&#x02009;&#x000b1;&#x02009;22.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 cognitions</td><td align="center" valign="top" rowspan="1" colspan="1">23.23&#x02009;&#x000b1;&#x02009;15.52</td><td align="center" valign="top" rowspan="1" colspan="1">31.88&#x02009;&#x000b1;&#x02009;19.64</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 communication</td><td align="center" valign="top" rowspan="1" colspan="1">24.31&#x02009;&#x000b1;&#x02009;20.86</td><td align="center" valign="top" rowspan="1" colspan="1">29.17&#x02009;&#x000b1;&#x02009;21.25</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 bodily discomfort</td><td align="center" valign="top" rowspan="1" colspan="1">31.67&#x02009;&#x000b1;&#x02009;21.92</td><td align="center" valign="top" rowspan="1" colspan="1">27.5&#x02009;&#x000b1;&#x02009;19.27</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 Total</td><td align="center" valign="top" rowspan="1" colspan="1">51.67&#x02009;&#x000b1;&#x02009;26.9</td><td align="center" valign="top" rowspan="1" colspan="1">50.8&#x02009;&#x000b1;&#x02009;29.43</td></tr></tbody></table><table-wrap-foot><p><italic>Data are mean&#x02009;&#x000b1;&#x02009;SD or as otherwise indicated</italic>.</p><p><italic>n, number of patients; NFOGQ, New Freezing of Gait Questionnaire; UPDRS, Unified Parkinson&#x02019;s Disease Rating Scale II and III; PDQ39, Parkinson&#x02019;s disease questionnaire 39; MPAS, Modified Parkinson&#x02019;s Activity Scale; BBS, Berg Balance Scale; 6MWT, 6-min walking test; TUG, Time-Up-and-Go; PDQ39, 39-item PD Questionnaire</italic>.</p></table-wrap-foot></table-wrap></sec><sec id="S2-3"><title>Experimental Procedures</title><p>All participants underwent to a 1&#x02009;h of rehabilitation training during their ON condition (approximately 1&#x02009;h after the antiparkinsonian medication intake), twice a week, for 8 consecutive weeks, and a total of 16 training sessions.</p><sec id="S2-3-1"><title>Experimental Group</title><p>The protocol was based on the AO method plus Sonification (AOS). During each training session, eight videos, showing an actor performing eight different motor gestures, were presented to the patient that then tried to repeat, according to the Modeling principles (<xref rid="B28" ref-type="bibr">28</xref>). Each video, lasting 1.5&#x02009;min, was composed by images (from fronto-lateral perspectives) and sounds (obtained with Sonification) of eight specific motor gestures. These gait related gestures were useful for ameliorating weight shifting, step scaling, and bilateral coordination of stepping, known as locomotion features related to FoG. In each session, all videos were presented, from simple to complex motor actions. The contents of the eight videos are reported in Appendix. Each session started with the observation of the audio&#x02013;video projected on a large sized screen (2.5&#x02009;m&#x02009;&#x000d7;&#x02009;2&#x02009;m) located in front of the patient at a distance of 2&#x02009;m. During AO, to increase the accuracy of imitation, patients were asked to attend to the peculiar characteristics of the observed action, and no movements were allowed. At the beginning, after video observation, patients had to practice repetitively the observed actions for the same time (1.5&#x02009;min). Then, patients performed <italic>on line</italic> the same motor gesture while they were watching the videos. With the aim to facilitate the modeling process, an expert physiotherapist in AO treatment, encouraged and corrected patient&#x02019;s motor execution. Each video was repeated twice.</p></sec><sec id="S2-3-2"><title>Control Group</title><p>The same eight motor gestures were performed also in the Cue control group with the same order and amount of time, by using attentional strategies. During each training session, patients were asked to practice the motor gesture by means of visual (stripes on the floor) or auditory (metronome) cues, to facilitate the learning of temporal and spatial parameters. As for the experimental group, the expert physiotherapist encouraged and corrected each patient&#x02019;s motor execution to facilitate correct motor learning process. Following physical therapist&#x02019;s instructions, patients progressively learned to perform the eight motor gestures without cues.</p><p>Participants of both groups were instructed to not practice further rehabilitation/physiotherapy treatments during the duration of the study. The two therapists involved in the treatments were not dedicated to one group, but equally assigned to both of them.</p></sec></sec><sec id="S2-4"><title>Clinical Outcomes</title><p>The patients who met inclusion/exclusion criteria underwent to a clinical and motor functional evaluation before the treatment (BT), after the treatment (AT), 1&#x02009;month (1MFU), and 3&#x02009;months AT (3MFU). The neuropsychological evaluations were only done at the baseline and 1&#x02009;month (1MFU) AT, since the minimum interval for test administration is 3&#x02009;months. All clinical evaluations were performed by an experienced neurologist, and a physiotherapist blinded to participants&#x02019; allocation.</p><p>As primary outcome, FOG duration and severity were assessed by using New Freezing of Gait Questionnaire (NFOGQ). Particularly, we calculate an index of improvement obtained at AT, 1MFU, and 3MFU evaluations, respect to the BT evaluation (see <xref ref-type="sec" rid="S2-6">Data Analysis</xref>).</p><p><italic>A priori</italic> power analyses based on a previous experiment that compared the two treatment protocols in individuals with PD and FoG (<xref rid="B29" ref-type="bibr">29</xref>), suggested 10 participants per group to achieve a medium effect size (<italic>f</italic>&#x02009;=&#x02009;0.45, alpha <italic>p</italic>&#x02009;=&#x02009;0.05, power&#x02009;=&#x02009;0.95, critical <italic>F</italic>&#x02009;=&#x02009;4.41). We recruited 12 participants for each group to account for possible attenuation.</p><p>As for the secondary outcomes, disease severity was tested with the Unified Parkinson&#x02019;s Disease Rating Scale (UPDRS II&#x02013;III), the Hoehn and Yahr scale (<xref rid="B25" ref-type="bibr">25</xref>), and quality of life with the 39-item PD Questionnaire (<xref rid="B30" ref-type="bibr">30</xref>). Motor functional performance evaluation included Modified Parkinson&#x02019;s Activity Scale (<xref rid="B31" ref-type="bibr">31</xref>), Timed Up and Go (<xref rid="B32" ref-type="bibr">32</xref>), and 6-min walking test (<xref rid="B33" ref-type="bibr">33</xref>). Berg Balance Scale (<xref rid="B34" ref-type="bibr">34</xref>) was used to assess static and dynamic balance capabilities. Also for the secondary outcome measures, we calculated an improvement index.</p><sec id="S2-4-1"><title>Neuropsychological Evaluation</title><p>We assessed patients&#x02019; most important cognitive functions, useful for learning new motor ability: executive functions, attention, and memory capabilities (Table <xref ref-type="table" rid="T2">2</xref>), to exclude that the cognitive profile of the patients of each group was changed after the end of the treatments. This was important to exclude that different levels of efficacy were due to differences in the cognitive profile of the two groups of patients. Global cognitive functioning was tested with the Montreal Cognitive Assessment (<xref rid="B35" ref-type="bibr">35</xref>); short-term and long-term memory functions with Digit Span backward (<xref rid="B36" ref-type="bibr">36</xref>), Corsi Test (<xref rid="B37" ref-type="bibr">37</xref>), Babcock Story Recall Test (<xref rid="B38" ref-type="bibr">38</xref>); attention with the Attentive Matrices (<xref rid="B39" ref-type="bibr">39</xref>), the Stroop Test (<xref rid="B40" ref-type="bibr">40</xref>), and Trail Making Test: parts A and B (<xref rid="B41" ref-type="bibr">41</xref>). Executive functions were evaluated with the Frontal Assessment Battery (<xref rid="B42" ref-type="bibr">42</xref>) and Tower of London Test (<xref rid="B43" ref-type="bibr">43</xref>). Abstract reasoning by Raven matrices (<xref rid="B44" ref-type="bibr">44</xref>). All neuropsychological tests scores were corrected on age, sex, and education using normative values. Moreover, patients were always tested in &#x0201c;ON&#x0201d; condition during their optimal antiparkinsonian medication.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Cognitive profile of patients with Parkinson&#x02019;s disease at baseline and at 1-month follow-up (1MFU).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="3" colspan="1">Cognitive domain</th><th valign="top" align="left" rowspan="3" colspan="1">Test</th><th valign="top" align="center" rowspan="1" colspan="1">AOS group at baseline</th><th valign="top" align="center" rowspan="1" colspan="1">Cue group at baseline</th><th valign="top" align="center" rowspan="1" colspan="1">AOS group at 1MFU</th><th valign="top" align="center" rowspan="1" colspan="1">Cue group at 1MFU</th></tr><tr><th valign="top" align="left" colspan="4" rowspan="1"><hr/></th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Mean&#x02009;&#x000b1;&#x02009;SD</th><th valign="top" align="center" rowspan="1" colspan="1">Mean&#x02009;&#x000b1;&#x02009;SD</th><th valign="top" align="center" rowspan="1" colspan="1">Mean&#x02009;&#x000b1;&#x02009;SD</th><th valign="top" align="center" rowspan="1" colspan="1">Mean&#x02009;&#x000b1;&#x02009;SD</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="2" colspan="1">Short-term memory</td><td align="left" valign="top" rowspan="1" colspan="1">Digit Span Backward</td><td align="center" valign="top" rowspan="1" colspan="1">4.84&#x02009;&#x000b1;&#x02009;1.27</td><td align="center" valign="top" rowspan="1" colspan="1">4.84&#x02009;&#x000b1;&#x02009;1.14</td><td align="center" valign="top" rowspan="1" colspan="1">4.59&#x02009;&#x000b1;&#x02009;1.14</td><td align="center" valign="top" rowspan="1" colspan="1">4.58&#x02009;&#x000b1;&#x02009;1.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Corsi Test</td><td align="center" valign="top" rowspan="1" colspan="1">4.85&#x02009;&#x000b1;&#x02009;0.84</td><td align="center" valign="top" rowspan="1" colspan="1">4.34&#x02009;&#x000b1;&#x02009;0.84</td><td align="center" valign="top" rowspan="1" colspan="1">4.50&#x02009;&#x000b1;&#x02009;0.83</td><td align="center" valign="top" rowspan="1" colspan="1">5.01&#x02009;&#x000b1;&#x02009;1.44</td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">Long-term memory</td><td align="left" valign="top" rowspan="1" colspan="1">Babcock Story Recall Test</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Immediate recall</td><td align="center" valign="top" rowspan="1" colspan="1">5.78&#x02009;&#x000b1;&#x02009;1.51</td><td align="center" valign="top" rowspan="1" colspan="1">4.52&#x02009;&#x000b1;&#x02009;2.48</td><td align="center" valign="top" rowspan="1" colspan="1">5.27&#x02009;&#x000b1;&#x02009;1.62</td><td align="center" valign="top" rowspan="1" colspan="1">3.83&#x02009;&#x000b1;&#x02009;2.50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Delayed recall</td><td align="center" valign="top" rowspan="1" colspan="1">5.8&#x02009;&#x000b1;&#x02009;1.4</td><td align="center" valign="top" rowspan="1" colspan="1">4.41&#x02009;&#x000b1;&#x02009;3.07</td><td align="center" valign="top" rowspan="1" colspan="1">5.16&#x02009;&#x000b1;&#x02009;1.88</td><td align="center" valign="top" rowspan="1" colspan="1">3.41&#x02009;&#x000b1;&#x02009;3.27</td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="7" colspan="1">Attention</td><td align="left" valign="top" rowspan="1" colspan="1">Attentive Matrices</td><td align="center" valign="top" rowspan="1" colspan="1">40.94&#x02009;&#x000b1;&#x02009;8.35</td><td align="center" valign="top" rowspan="1" colspan="1">32.46&#x02009;&#x000b1;&#x02009;12.86</td><td align="center" valign="top" rowspan="1" colspan="1">36.91&#x02009;&#x000b1;&#x02009;11.27</td><td align="center" valign="top" rowspan="1" colspan="1">31.56&#x02009;&#x000b1;&#x02009;13.51</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Trail Making Test:</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Part A (s)</td><td align="center" valign="top" rowspan="1" colspan="1">30.35&#x02009;&#x000b1;&#x02009;21.59</td><td align="center" valign="top" rowspan="1" colspan="1">68.51&#x02009;&#x000b1;&#x02009;46.78</td><td align="center" valign="top" rowspan="1" colspan="1">52.44&#x02009;&#x000b1;&#x02009;45.98</td><td align="center" valign="top" rowspan="1" colspan="1">55.27&#x02009;&#x000b1;&#x02009;38.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Part B (s)</td><td align="center" valign="top" rowspan="1" colspan="1">147.34&#x02009;&#x000b1;&#x02009;116.51</td><td align="center" valign="top" rowspan="1" colspan="1">190.58&#x02009;&#x000b1;&#x02009;130.99</td><td align="center" valign="top" rowspan="1" colspan="1">148.35&#x02009;&#x000b1;&#x02009;199.33</td><td align="center" valign="top" rowspan="1" colspan="1">166.68&#x02009;&#x000b1;&#x02009;117.38</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Stroop Test</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Time (s)</td><td align="center" valign="top" rowspan="1" colspan="1">28.78&#x02009;&#x000b1;&#x02009;19.19</td><td align="center" valign="top" rowspan="1" colspan="1">52.73&#x02009;&#x000b1;&#x02009;42.05</td><td align="center" valign="top" rowspan="1" colspan="1">42.59&#x02009;&#x000b1;&#x02009;26.17</td><td align="center" valign="top" rowspan="1" colspan="1">47.72&#x02009;&#x000b1;&#x02009;29.42</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Errors</td><td align="center" valign="top" rowspan="1" colspan="1">3.01&#x02009;&#x000b1;&#x02009;3.55</td><td align="center" valign="top" rowspan="1" colspan="1">1.83&#x02009;&#x000b1;&#x02009;1.76</td><td align="center" valign="top" rowspan="1" colspan="1">3.64&#x02009;&#x000b1;&#x02009;2.47</td><td align="center" valign="top" rowspan="1" colspan="1">3.36&#x02009;&#x000b1;&#x02009;3.39</td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">Executive functions</td><td align="left" valign="top" rowspan="1" colspan="1">Frontal Assessment Battery</td><td align="center" valign="top" rowspan="1" colspan="1">16.7&#x02009;&#x000b1;&#x02009;1.22</td><td align="center" valign="top" rowspan="1" colspan="1">16.19&#x02009;&#x000b1;&#x02009;1.71</td><td align="center" valign="top" rowspan="1" colspan="1">16.55&#x02009;&#x000b1;&#x02009;1.78</td><td align="center" valign="top" rowspan="1" colspan="1">16.11&#x02009;&#x000b1;&#x02009;1.80</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tower of London Test</td><td align="center" valign="top" rowspan="1" colspan="1">17.99&#x02009;&#x000b1;&#x02009;1.4</td><td align="center" valign="top" rowspan="1" colspan="1">19.56&#x02009;&#x000b1;&#x02009;6.38</td><td align="center" valign="top" rowspan="1" colspan="1">18.61&#x02009;&#x000b1;&#x02009;0.29</td><td align="center" valign="top" rowspan="1" colspan="1">18.22&#x02009;&#x000b1;&#x02009;1.41</td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reasoning</td><td align="left" valign="top" rowspan="1" colspan="1">Raven&#x02019;s progressive matrices</td><td align="center" valign="top" rowspan="1" colspan="1">29.71&#x02009;&#x000b1;&#x02009;6.18</td><td align="center" valign="top" rowspan="1" colspan="1">27.28&#x02009;&#x000b1;&#x02009;5.17</td><td align="center" valign="top" rowspan="1" colspan="1">28.85&#x02009;&#x000b1;&#x02009;6.16</td><td align="center" valign="top" rowspan="1" colspan="1">27.70&#x02009;&#x000b1;&#x02009;5.31</td></tr></tbody></table><table-wrap-foot><p><italic>Data are mean&#x02009;&#x000b1;&#x02009;SD or as otherwise indicated</italic>.</p></table-wrap-foot></table-wrap></sec></sec><sec id="S2-5"><title>Audiovisual Stimuli</title><p>The short video used in the experimental group showed two healthy actors&#x02019; (one male and one female) performing the 8 motor gestures from a lateral and frontal perspective, for a total of 32 different videos (2 gender&#x02009;&#x000d7;&#x02009;8 gestures&#x02009;&#x000d7;&#x02009;2 perspectives). Moreover, prior rehabilitation treatment, and to be comfortable with the procedures, each participant practiced the tasks using other videos showing three movements test. The sounds of each video were obtained with the Sonification technique, by transforming kinematic data (i.e., velocity) recorded during the execution of the eight gestures, into audio pitch variations. Actors performed all tasks barefoot, walking along a 10-m walkway surrounded by a seven-camera motion-capture Qualisys System (120&#x02009;Hz). During the execution of each motor gestures, kinematic data were collected recording four retroflective markers placed on the left and right anterior superior iliac spine to calculate pelvis movement velocity, and on the left and right lateral malleoli to calculate inferior limbs velocity. All data were recorded and preprocessed by a dedicated software Qualisys Track Manager, and frame by frame instantaneous speed was obtained, and transformed into pitch audio by the open source framework Pd (<xref rid="B45" ref-type="bibr">45</xref>) using modules developed by Henkelmann and colleagues (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>). The Sonification itself is done in the following steps: first, median filter with a window size of three frames is applied to the kinematic data to suppress sensor noise from the kinematic data. Second, the data stream is linearly scaled to an interval from 0 to 1. Third, the pitch sound itself is generated. Forth, the sound is mapped to the left or right audio channel. The PD module we used to generate our stimuli can be found in the supplemental materials for this publication. 32 audio track were gained (2 actors gender&#x02009;&#x000d7;&#x02009;8 different gestures&#x02009;&#x000d7;&#x02009;2 perspectives) for each motor gestures, and 2 audio tracks for each movement test. Videos were edited by using Final Cut Pro X software, with a dubbing procedure to merge the sounds with the video part of each gesture. The kinematic&#x02013;acoustic recording was provided with a visual auditory stimulus congruence.</p></sec><sec id="S2-6"><title>Data Analysis</title><p>Preliminary, applying the Kolmogorov&#x02013;Smirnov (KS) test we verified the sustainability of a normal distribution for the primary and secondary clinical outcomes. Highly skewed and kurtotic variables were log transformed and then KS tested for the effectiveness of the correction. Outcomes that failed this second test where excluded from the analysis.</p><p>For each clinical outcome, the improvement (gain) from pretraining to posttraining (AT, 1MFU, and 3MFU) was computed for each participant by subtracting each person&#x02019;s pretraining score from his/her posttraining score and dividing the difference for the pretraining performance. Formally:
<disp-formula id="E1"><mml:math id="M1"><mml:mrow><mml:mtext>gain</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>post-training</mml:mtext><mml:mo>&#x02212;</mml:mo><mml:mtext>pre-training</mml:mtext></mml:mrow><mml:mrow><mml:mtext>pre-training</mml:mtext></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p>Systematic differences in pretraining scores between the two groups of patients were preliminary excluded with <italic>t</italic>-tests on both primary and secondary outcomes measures. As for the cognitive profile, we verified for potential differences in the pretraining (BT) and modification after 3&#x02009;months (1MFU) with a 2&#x02009;&#x000d7;&#x02009;2 mixed factors ANOVA (Group and Time of evaluation). The results are reported in Table <xref ref-type="table" rid="T3">3</xref>.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Split plot ANOVA results.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">SS</th><th valign="top" align="center" rowspan="1" colspan="1">Mean sq</th><th valign="top" align="center" rowspan="1" colspan="1">F</th><th valign="top" align="center" rowspan="1" colspan="1">Pr(&#x0003e;F)</th><th valign="top" align="center" rowspan="1" colspan="1">&#x003b7;<sup>2</sup>G (%)</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="6" rowspan="1"><bold>Main effect of treatment (Group)</bold></td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><bold>Primary outcome measure</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NFOGQ</td><td align="center" valign="top" rowspan="1" colspan="1">2.741</td><td align="center" valign="top" rowspan="1" colspan="1">2.741</td><td align="center" valign="top" rowspan="1" colspan="1">24.28</td><td align="center" valign="top" rowspan="1" colspan="1">0.000</td><td align="center" valign="top" rowspan="1" colspan="1">50</td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><bold>Secondary outcome measures</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 mobility</td><td align="center" valign="top" rowspan="1" colspan="1">12.630</td><td align="center" valign="top" rowspan="1" colspan="1">12.633</td><td align="center" valign="top" rowspan="1" colspan="1">14.91</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">38</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UPDRSIII</td><td align="center" valign="top" rowspan="1" colspan="1">4.962</td><td align="center" valign="top" rowspan="1" colspan="1">4.962</td><td align="center" valign="top" rowspan="1" colspan="1">13.36</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">33</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 bodily discomfort</td><td align="center" valign="top" rowspan="1" colspan="1">4.962</td><td align="center" valign="top" rowspan="1" colspan="1">4.962</td><td align="center" valign="top" rowspan="1" colspan="1">13.36</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">33</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 Total</td><td align="center" valign="top" rowspan="1" colspan="1">2.031</td><td align="center" valign="top" rowspan="1" colspan="1">2.031</td><td align="center" valign="top" rowspan="1" colspan="1">9.73</td><td align="center" valign="top" rowspan="1" colspan="1">0.006</td><td align="center" valign="top" rowspan="1" colspan="1">27</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UPDRSII</td><td align="center" valign="top" rowspan="1" colspan="1">1.427</td><td align="center" valign="top" rowspan="1" colspan="1">1.427</td><td align="center" valign="top" rowspan="1" colspan="1">11.14</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td><td align="center" valign="top" rowspan="1" colspan="1">24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BBS</td><td align="center" valign="top" rowspan="1" colspan="1">0.121</td><td align="center" valign="top" rowspan="1" colspan="1">0.121</td><td align="center" valign="top" rowspan="1" colspan="1">6.42</td><td align="center" valign="top" rowspan="1" colspan="1">0.020</td><td align="center" valign="top" rowspan="1" colspan="1">24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6MWT</td><td align="center" valign="top" rowspan="1" colspan="1">0.470</td><td align="center" valign="top" rowspan="1" colspan="1">0.470</td><td align="center" valign="top" rowspan="1" colspan="1">4.11</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TUG</td><td align="center" valign="top" rowspan="1" colspan="1">1.070</td><td align="center" valign="top" rowspan="1" colspan="1">1.071</td><td align="center" valign="top" rowspan="1" colspan="1">3.95</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MPAS</td><td align="center" valign="top" rowspan="1" colspan="1">0.021</td><td align="center" valign="top" rowspan="1" colspan="1">0.021</td><td align="center" valign="top" rowspan="1" colspan="1">0.56</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 cognitions</td><td align="center" valign="top" rowspan="1" colspan="1">0.471</td><td align="center" valign="top" rowspan="1" colspan="1">0.471</td><td align="center" valign="top" rowspan="1" colspan="1">0.47</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><bold>Main effect Time (within subjects)</bold></td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><bold>Primary outcome measure</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NFOGQ</td><td align="center" valign="top" rowspan="1" colspan="1">0.091</td><td align="center" valign="top" rowspan="1" colspan="1">0.046</td><td align="center" valign="top" rowspan="1" colspan="1">3.11</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><bold>Secondary outcome measures</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 mobility</td><td align="center" valign="top" rowspan="1" colspan="1">0.151</td><td align="center" valign="top" rowspan="1" colspan="1">0.075</td><td align="center" valign="top" rowspan="1" colspan="1">0.60</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UPDRSIII</td><td align="center" valign="top" rowspan="1" colspan="1">0.334</td><td align="center" valign="top" rowspan="1" colspan="1">0.167</td><td align="center" valign="top" rowspan="1" colspan="1">2.14</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 bodily discomfort</td><td align="center" valign="top" rowspan="1" colspan="1">0.334</td><td align="center" valign="top" rowspan="1" colspan="1">0.167</td><td align="center" valign="top" rowspan="1" colspan="1">2.14</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 Total</td><td align="center" valign="top" rowspan="1" colspan="1">0.158</td><td align="center" valign="top" rowspan="1" colspan="1">0.079</td><td align="center" valign="top" rowspan="1" colspan="1">2.05</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UPDRSII</td><td align="center" valign="top" rowspan="1" colspan="1">0.049</td><td align="center" valign="top" rowspan="1" colspan="1">0.025</td><td align="center" valign="top" rowspan="1" colspan="1">0.48</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BBS</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td><td align="center" valign="top" rowspan="1" colspan="1">3.01</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6MWT</td><td align="center" valign="top" rowspan="1" colspan="1">0.061</td><td align="center" valign="top" rowspan="1" colspan="1">0.031</td><td align="center" valign="top" rowspan="1" colspan="1">2.91</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TUG</td><td align="center" valign="top" rowspan="1" colspan="1">0.222</td><td align="center" valign="top" rowspan="1" colspan="1">0.111</td><td align="center" valign="top" rowspan="1" colspan="1">3.66</td><td align="center" valign="top" rowspan="1" colspan="1">0.035</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MPAS</td><td align="center" valign="top" rowspan="1" colspan="1">0.009</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td><td align="center" valign="top" rowspan="1" colspan="1">0.69</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 cognitions</td><td align="center" valign="top" rowspan="1" colspan="1">1.546</td><td align="center" valign="top" rowspan="1" colspan="1">0.773</td><td align="center" valign="top" rowspan="1" colspan="1">4.17</td><td align="center" valign="top" rowspan="1" colspan="1">0.023</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><bold>Interaction effect (Time&#x02009;&#x000d7;&#x02009;Group)</bold></td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><bold>Primary outcome measure</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NFOGQ</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.07</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><bold>Secondary outcome measures</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 mobility</td><td align="center" valign="top" rowspan="1" colspan="1">0.386</td><td align="center" valign="top" rowspan="1" colspan="1">0.193</td><td align="center" valign="top" rowspan="1" colspan="1">1.54</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UPDRSIII</td><td align="center" valign="top" rowspan="1" colspan="1">0.197</td><td align="center" valign="top" rowspan="1" colspan="1">0.098</td><td align="center" valign="top" rowspan="1" colspan="1">1.26</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 bodily discomfort</td><td align="center" valign="top" rowspan="1" colspan="1">0.197</td><td align="center" valign="top" rowspan="1" colspan="1">0.098</td><td align="center" valign="top" rowspan="1" colspan="1">1.26</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 Total</td><td align="center" valign="top" rowspan="1" colspan="1">0.261</td><td align="center" valign="top" rowspan="1" colspan="1">0.131</td><td align="center" valign="top" rowspan="1" colspan="1">3.41</td><td align="center" valign="top" rowspan="1" colspan="1">0.043</td><td align="center" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UPDRSII</td><td align="center" valign="top" rowspan="1" colspan="1">0.047</td><td align="center" valign="top" rowspan="1" colspan="1">0.023</td><td align="center" valign="top" rowspan="1" colspan="1">0.46</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BBS</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.90</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6MWT</td><td align="center" valign="top" rowspan="1" colspan="1">0.022</td><td align="center" valign="top" rowspan="1" colspan="1">0.011</td><td align="center" valign="top" rowspan="1" colspan="1">1.03</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TUG</td><td align="center" valign="top" rowspan="1" colspan="1">0.034</td><td align="center" valign="top" rowspan="1" colspan="1">0.017</td><td align="center" valign="top" rowspan="1" colspan="1">0.56</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MPAS</td><td align="center" valign="top" rowspan="1" colspan="1">0.014</td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td><td align="center" valign="top" rowspan="1" colspan="1">1.02</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 cognitions</td><td align="center" valign="top" rowspan="1" colspan="1">0.451</td><td align="center" valign="top" rowspan="1" colspan="1">0.225</td><td align="center" valign="top" rowspan="1" colspan="1">1.22</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr></tbody></table><table-wrap-foot><p><italic>ns, not significant; NFOGQ, New Freezing of Gait Questionnaire; UPDRS, Unified Parkinson&#x02019;s Disease Rating Scale II and III; PDQ39: Parkinson&#x02019;s disease questionnaire 39; MPAS, Modified Parkinson&#x02019;s Activity Scale; BBS, Berg Balance Scale; 6MWT, 6-min walking test; TUG, Time-Up-and-Go; PDQ39, 39-item PD Questionnaire; SS, sum of squares</italic>.</p><p><italic>UPDRSIII, TUG, PDQ39 mobility, and PDQ39 bodily discomfort were log transformed for normality. Index &#x003b7;<sup>2</sup>G is the generalized eta-squared statistics calculated following the guidelines by Olejnik and Algina (<xref rid="B48" ref-type="bibr">48</xref>) and Bakeman (<xref rid="B49" ref-type="bibr">49</xref>). For the two main effects and interaction tested we used the formulas SSA/(SSA&#x02009;+&#x02009;SSs/A&#x02009;+&#x02009;SSPs/A), SSP/(SSP&#x02009;+&#x02009;SSs/A&#x02009;+&#x02009;SSPs/A) and SSPA/(SSPA&#x02009;+&#x02009;SSs/A&#x02009;+&#x02009;SSPs/A), where A and P refer to our variables Group and Time, respectively, and s represents the subject factor. Errors related SS are not shown in this table</italic>.</p></table-wrap-foot></table-wrap><p>The hypothesis of differences in improvement (gain) between the experimental and control groups was tested by a mixed design ANOVA on the gain scores using <italic>Group</italic> (AOS vs. Cue) as a between subjects factor, and <italic>Time of evaluation</italic> as within-subject factor. Besides main effects, we also considered the interaction terms <italic>Group</italic>&#x02009;&#x000d7;&#x02009;<italic>Time</italic> to assess the stability of the effect across evaluation. <italic>Post hoc</italic> Bonferroni&#x02019;s test was employed to assess gain score differences between groups at each time. The significant change threshold was set at <italic>p</italic>&#x02009;&#x02264;&#x02009;0.05. We interpreted the meaningfulness of the significant changes using the generalized eta-squared (&#x003b7;<sup>2</sup>G) statistics calculated following the guidelines by Olejnik and Algina (<xref rid="B48" ref-type="bibr">48</xref>) and Bakeman (<xref rid="B49" ref-type="bibr">49</xref>).</p><sec id="S2-6-1"><title>Linear Discriminant Analysis (LDA)</title><p>Besides these statistical criteria, to examine the clinical impact of the AOS and Cue training on outcomes scores, we used also an automated classification rates criterion. This method is commonly used as a technique for pattern classification. In our case, we used this method to compare or classify the clinical profiles of the patients in the two groups, and at the different stages of the experimental study. Automated classification problems involve continuous input variables (i.e., our clinical scales), and categorical outcomes (i.e., the rehabilitation protocol or the stage of the study). The algorithm has to learn to predict the category from the input data. We used an LDA algorithm in two differ ways, to discriminate between groups and within subjects. Finally, we choose to complement standard analysis of variance with this LDA because of recommendations on using simulative approaches to data analysis with small samples (<xref rid="B50" ref-type="bibr">50</xref>).</p><p>First, the algorithm learned between-groups&#x02019; discriminative criterion on a fraction of 70% of the data set, then for testing we applied the criterion on the remaining fraction of 30% (see <xref ref-type="sec" rid="S8">Supplementary Material</xref>), measuring the classification accuracy in terms of sensitivity index (<xref rid="B51" ref-type="bibr">51</xref>). Average sensitivities were based on a complete random design, simulating all possible combination of 70&#x02013;30% of the participants (<xref rid="B50" ref-type="bibr">50</xref>). Particularly, we trained and tested the LDA four times, over each evaluation time (BT, AT, 1MFU, and 3MFU), and considering the rehabilitation protocol attended by participants as the categorical outcome to predict.</p><p>Second, to evaluate stability over time, as in the case of interaction term in the ANOVA, we considered within-subject evaluations, using the LDA algorithm on a subset composed by 70% of pre- and posttraining individual&#x02019;s outcomes, and testing it on the remaining 30% of pre- and posttraining individual&#x02019;s outcomes.</p><p>In both cases, we expect that the more effective is the training in transforming the participants clinical profile, the more accurate is the LDA algorithm in (learn to) classify the participants within the training actually practiced. In the first LDA implementation, we expect that the LDA classification would fail only in the comparison between the two groups at the BT time window.</p><p>All the analyses were programmed using R statistical language (<xref rid="B52" ref-type="bibr">52</xref>).</p></sec></sec></sec><sec id="S3"><title>Results</title><p>At the baseline, there were no significant differences between groups with respect to demographics and clinical records, as shown in Table <xref ref-type="table" rid="T1">1</xref>. Also for the cognitive profile, as reported in Table <xref ref-type="table" rid="T2">2</xref>, there was no differences except for the interaction Group&#x02009;&#x000d7;&#x02009;Time in the Corsi test [<italic>F</italic><sub>(1,20)</sub>&#x02009;=&#x02009;5.975, <italic>p</italic>&#x02009;=&#x02009;0.024, &#x003b7;<sup>2</sup>&#x02009;=&#x02009;0.225], but when we compared the two groups in the two moments with a <italic>t</italic>-test, the difference was not significant [<italic>t</italic>(20)&#x02009;=&#x02009;1.449, <italic>p</italic>&#x02009;=&#x02009;0.163; <italic>t</italic>(20)&#x02009;=&#x02009;&#x02212;0.480, <italic>p</italic>&#x02009;=&#x02009;0.636].</p><sec id="S3-1"><title>Primary Outcome Measure</title><p>Action observation plus Sonification treatment had a significant positive effect in reducing the primary outcome measure, participant&#x02019;s ratings of FoG severity and duration, as shown at the end of the treatment, and most important, at the second follow-up (Figure <xref ref-type="fig" rid="F2">2</xref>, NFOGQ). Noteworthy, on our sample the standard Cue protocol did not show any relevant gain effect from the baseline evaluation.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Improvement (gain) of the two groups in the primary outcome measure [New Freezing of Gait Questionnaire (NFOGQ)], at the three evaluation times. Error bars are 1 SE.</p></caption><graphic xlink:href="fneur-08-00723-g002"/></fig></sec><sec id="S3-2"><title>Secondary Outcome Measures</title><p>Secondary outcome measures that improved in AOS (Figure <xref ref-type="fig" rid="F3">3</xref>) were as follows: severity of motor impairment (UPDRS III); motor problems, and bodily discomfort in activity of daily life (the mobility and bodily discomfort subscales of the PDQ39 questionnaire). For this pool of outcome measures, the positive effect of AOS treatment over Cue training has a great effect size (&#x003b7;<sup>2</sup>G&#x02009;&#x0003e;&#x02009;0.30) and is stable until the last follow-up (see <italic>post hoc</italic> comparisons reported in Table <xref ref-type="table" rid="T4">4</xref>). Even in these measures, the standard Cue protocol did not show any relevant gain effect. Figures <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F3">3</xref> show the gain scores of the main effects.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Improvement (gain) of the two groups in five secondary outcome measures [Unified Parkinson&#x02019;s Disease Rating Scale: parts II and III (UPDRS) and Parkinson&#x02019;s disease questionnaire 39 (PDQ39): mobility, bodily discomfort, and the total score], at the three evaluation times. Error bars are 1 SE.</p></caption><graphic xlink:href="fneur-08-00723-g003"/></fig><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Bonferroni <italic>post hoc</italic> comparisons AOS group vs. cue group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">After treatment</th><th valign="top" align="center" rowspan="1" colspan="1">1st Follow-up</th><th valign="top" align="center" rowspan="1" colspan="1">2nd Follow-up</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="4" rowspan="1"><bold>Primary outcome measure</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NFOGQ</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.001</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.001</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.001</td></tr><tr><td align="left" valign="top" colspan="4" rowspan="1"><bold>Secondary outcome measures</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 mobility</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.05</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.001</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UPDRSIII</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.001</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.05</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 bodily discomfort</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.001</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.05</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 Total</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.01</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UPDRSII</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.05</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BBS</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.05</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6MWT</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>&#x02009;&#x02264;&#x02009;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TUG</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MPAS</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PDQ39 cognitions</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td><td align="center" valign="top" rowspan="1" colspan="1">ns</td></tr></tbody></table><table-wrap-foot><p><italic>Data are p-levels of the direct comparisons at each evaluation time, between groups, after the Bonferroni correction</italic>.</p><p><italic>NFOGQ, New Freezing of Gait Questionnaire; UPDRS, Unified Parkinson&#x02019;s Disease Rating Scale II and III; PDQ39, Parkinson&#x02019;s disease questionnaire 39; MPAS, Modified Parkinson&#x02019;s Activity Scale; BBS, Berg Balance Scale; 6MWT, 6-min walking test; TUG, Time-Up-and-Go; ns, not significant</italic>.</p></table-wrap-foot></table-wrap><p>Table <xref ref-type="table" rid="T3">3</xref> reports <italic>F</italic>-tests for main effects and interaction separately, for all outcomes considered, whereas Table <xref ref-type="table" rid="T4">4</xref> reports direct comparisons at each evaluation time, between groups.</p><p>At first glance, for nearly all secondary outcomes, the group factor (the main effect of rehabilitation protocol) had the greater effect size (&#x003b7;<sup>2</sup>G). These effects are stable over time since interaction terms are not significant and/or with negligible amounts of variance explained.</p><p>The problems in activity of daily living (PDQ39 total score, UPDRS II) were significantly reduced by AOS training, with stable results also after 3&#x02009;months. Moreover, AOS training determined also a small improvement on average gain scores of motor balance (BBS, see Tables <xref ref-type="table" rid="T3">3</xref> and <xref ref-type="table" rid="T4">4</xref>).</p></sec><sec id="S3-3"><title>Linear Discriminant Analysis</title><p>We trained an LDA algorithm to learn to discriminate between rehabilitation protocols attended by participants, using as input variables significant outcomes identified by ANOVA. Particularly, inclusion criteria were the following: (a) significant main effect on group factor and great effect size (&#x0003e;0.30), (b) stable result over evaluation time (no interaction in Table <xref ref-type="table" rid="T1">1</xref> and significant <italic>post hoc</italic> comparisons in Table <xref ref-type="table" rid="T3">3</xref>). Input variables were the raw data, not transformed into gain scores. Figure <xref ref-type="fig" rid="F4">4</xref>A shows average discrimination accuracy, expressed in terms of sensitivity&#x02014;i.e., SDs from chance (<xref rid="B51" ref-type="bibr">51</xref>). At the baseline, the algorithm could not learn a reliable criterion to recognize &#x0201c;AOS&#x0201d; or &#x0201c;Cue&#x0201d; participants since their clinical profiles are homogeneous (Table <xref ref-type="table" rid="T2">2</xref>) and hence its performance stops to a chance level. Immediately AT, at 1&#x02009;month, and after 3&#x02009;months, experimental protocol differentiates participant&#x02019;s outcomes from the baseline levels and the algorithm can learn a criterion that move the performance (nearly) 1 SD from the chance. Importantly, the effect is far more evident considering the mobility outcome (NFOGQ and UPDRS III), over the improvement in ability of daily activities (PDQ39 mobility and bodily discomfort).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Average discrimination accuracy expressed in terms of sensitivity (<italic>d</italic>&#x02032;) of the linear discriminant analysis (LDA) algorithm. <bold>(A)</bold> Results of testing between-groups&#x02019; discrimination. Dark gray bars represent LDA results from the New Freezing of Gait Questionnaire (NFOGQ) and UPDRS III scales. Light gray bars represent LDA results from the PDQ39 mobility and bodily discomfort scales. <bold>(B)</bold> Results of testing within-subject discrimination. Dark and light red bars represent LDA results from the NFOGQ and UPDRS III scales for the Action Observation plus Sonification experimental group. Dark and light blue bars represent LDA results from the PDQ39 mobility and bodily discomfort scales, for the Cue control group.</p></caption><graphic xlink:href="fneur-08-00723-g004"/></fig><p>Furthermore, using the same input variables, we trained an LDA algorithm to discriminate each participant&#x02019;s pre- and posttraining conditions, within each group; Figure <xref ref-type="fig" rid="F4">4</xref>B shows average sensitivity index, separately for the AOS and Cue conditions. Participants trained with experimental AOS protocol were discriminable with respect to their baseline condition to an extent of 2 SD from chance, using clinical motor profile, and this result is quite stable over time. The ability of the algorithm to learn systematically a criterion over the chance was not proven, within participant&#x02019;s undergoing rehabilitation with Cue.</p></sec></sec><sec sec-type="discussion" id="S4"><title>Discussion</title><p>Sonification and AO are used together for the first time with the aim to treat motor diseases in PD patients with FoG. The main finding of our study is that this multisensory treatment reduces FoG (number of episodes and duration), and provided positive effects on gait pattern in short- and long-term period.</p><p>These results are in agreement with those obtained in two previous studies with the use of AO: Pelosin et al. (<xref rid="B29" ref-type="bibr">29</xref>) and Agosta et al. (<xref rid="B53" ref-type="bibr">53</xref>). In both these studies, freezing improvements (assessed with FOGQ and NFOGQ, respectively) were evaluated only up to 1&#x02009;month after the end of the treatment&#x02014;instead of three&#x02014;and with mixed and weak results&#x02014;Pelosin&#x02019;s data showed a significant improvement at the 1-month follow-up, but not at the end of the treatment, and the reverse pattern in the Agosta&#x02019;s. Our data with AO plus Sonification showed consistent and significant effects in several of the secondary outcome measures: on motor impairment (UPDRS III), and quality of life (PDQ39 mobility scale), during the entire 3-month period of evaluation; while balance (BBS), gait parameters (6MWT), only at the first and second follow-up, respectively. Overall, our data confirmed the therapeutic potential of a protocol based on AO plus Sonification in treating gait disorders and FoG. In AOS group, patients improved their mobility, acquiring new motor strategies to overcome FoG, and these effects are prolonged over time and generalized to FoG in daily life.</p><p>In Cue control group, no enhancements were found for all mobility indices, throughout the three testing times. Only data in PDQ39 questionnaire subitem mobility and activities daily living show trend values toward an improvement, that with a larger sample, could lead to significance. A possible explanation is a residual cue dependence effect, which may have not triggered an effective learning process (<xref rid="B54" ref-type="bibr">54</xref>), and pointing out that evidences on the effectiveness of cue trainings in the alleviation of FoG symptoms is still a hot topic. Another potential factor could be the age of our sample. Although the two groups were not statistically different in age and stage of the disease, overall our patients were quite old (73&#x02009;years). Probably, older patients may require a more specific training to engage a motor consolidation process when a standard protocol based on external sensory cues is used. Indeed, it should be emphasized the lower mean age of participants with PD and FoG in previous studies [66&#x02009;years&#x02014;Agosta et al. (<xref rid="B53" ref-type="bibr">53</xref>); 66&#x02009;years&#x02014;Lu et al. (<xref rid="B55" ref-type="bibr">55</xref>); 62&#x02009;years&#x02014;Young et al. (<xref rid="B9" ref-type="bibr">9</xref>)], when compared with the ones of our research. This age difference could have produced an additional decline in motor learning (<xref rid="B56" ref-type="bibr">56</xref>). In a crossover design with old patients with PD and FoG (mean age, 74&#x02009;years), Bunting-Perry et al. (<xref rid="B57" ref-type="bibr">57</xref>)&#x02014;using a laser beam on a rolling walker as a visual cue&#x02014;showed no significant effects in diminishing FoG and improving walking.</p><p>The peculiar feature and novelty of our approach is the inclusion of a sonified audio track&#x02014;representing kinematic features of a movement&#x02014;to the video of the same movement. In other words, we used the Sonification to highlight task-intrinsic (spatial and temporal) information, otherwise difficult to access. This <italic>augmented</italic> stimulus is very different from those typically employed in AO treatments, since usually the sound part is absent (<xref rid="B29" ref-type="bibr">29</xref>), or not related in meaning to the content of the video [not congruent multisensory stimulus as in Ref. (<xref rid="B53" ref-type="bibr">53</xref>)]. When a patient attends to a stimulus with a sound cue (i.e., metronome) presented together with a video of an action, the amount of cognitive resources necessary to integrate the information of the two stimuli&#x02014;not related in meaning&#x02014;increase [for a review, see Ref. (<xref rid="B58" ref-type="bibr">58</xref>)]. In our protocol, the videos are congruent multisensory stimuli, in the sense that sounds and images are related in meaning, and probably bound together at the perceptual level. This conclusion is based on patients&#x02019; personal reports; they all reported to perceive stimuli as being highly consistent, and treated them as a single audiovisual event [the unity assumption&#x02014;for a recent review, see Ref. (<xref rid="B59" ref-type="bibr">59</xref>)]. In fact, during the training, we did not need to use any particular type of instruction&#x02014;except that the sound simply derived from the velocity of the movement&#x02014;to let patient understand the meaning of sonified sounds, and the relation between the two sources of information (sound and image). After the presentation of the examples, the meaning of the stimuli became clear to almost all patients, and for those with some doubts, the presentation of the first stimulus was sufficient to understand.</p><p>The observation of action activates in humans the mirror neuron system (MNS) within the premotor cortex, inferior frontal gyrus, and inferior parietal lobule, that maps sensory signal onto the same neural circuits involved in motor planning and execution of the observed motor gesture. Congruent Sonification may have improved AO priming effect on movement. Indeed, during congruent audiovisual stimuli observation, Schmitz et al. (<xref rid="B17" ref-type="bibr">17</xref>) demonstrated an amplified activation of some of the major MNS areas, particularly frontal operculum, inferior parietal lobule and the superior temporal areas. Thanks to an enhanced perceptual analysis of the movement, congruent Sonification could lead to an improved neural representation of the observed motor action, and to an easier learning process thanks to a lightened cognitive load.</p><p>Motor learning involves the interaction of several components (<xref rid="B60" ref-type="bibr">60</xref>): extraction and processing of task-relevant sensory information, making decision aimed to define which movements to perform (and in which order), activating control processes, and finally a reactive and biomechanical control. A multisensory AO plus Sonification protocol might have aided the first phase of motor learning, facilitating the extraction and integration of visual and coherent auditory inputs, for a better understanding of spatial and temporal features of motor action.</p><p>Moreover, we hypothesize that our multisensory protocol&#x02014;based on congruent and unitary stimuli&#x02014;could have produced positive effects on memory, and specifically working memory processes. In fact, Lehmann and Murray (<xref rid="B15" ref-type="bibr">15</xref>) showed that semantically congruent multisensory stimuli can enhance subsequent processing and memory performance, and more recently Brunetti et al. (<xref rid="B61" ref-type="bibr">61</xref>) demonstrated that crossmodal correspondence (i.e., audiovisual congruent stimuli) produced faster reaction times and higher accuracy in a classical working memory task (<italic>n</italic>-back task). Given these findings, and given that PD patients are known be impaired in working memory processes [see, for example, Ref. (<xref rid="B62" ref-type="bibr">62</xref>)], the use of multisensory stimuli could have facilitated the processing and consequently the production of more effective gait patterns.</p><p>Sonification, as alternative, can be used in a rehabilitation program for patient with PD by generating additional real-time movement information, being suitable for integration with visual and proprioceptive perceptual feedback, while the patient is performing physical exercises. With ongoing training activity, synchronously processed auditory information should be initially integrated into the emerging internal models, enhancing the efficacy of motor learning. This is achieved by a direct mapping of kinematic and dynamic motion parameters to electronic sounds, resulting in continuous auditory and convergent audiovisual or audio-proprioceptive stimulus arrays.</p><p>A critical analysis of protocols&#x02019; features emphasize that learning strategies used in the two groups could be also partially different in terms of learning mechanisms. Indeed, they are more related to a modeling process&#x02014;with movement-related analogic representations&#x02014;in the experimental group, while in the control group followed a cueing approach&#x02014;with abstract and propositional representations. Agosta et al. (<xref rid="B53" ref-type="bibr">53</xref>) used a similar experimental design with a control group that underwent to a motor learning process by instructions and an experimental group that improved motor action by AO. In our control group, we used visual and auditory cue whose effectiveness had already been stressed by several studies in PD patients with FoG, and these results could be also considered as a further confirmation of the effectiveness of the AO therapy.</p><p>The combination in our AO plus Sonification protocol of a multisensory and analogic approach instead of a unisensory and abstract approach, produced promising positive effects, although we cannot evaluate nor the relative impact of each component, neither the effect of their interaction. However, this matter remains to be fully address.</p><p>Finally, as for the long-lasting effects, our protocol was a not intensive 8-week training program, which is not a long rehabilitative period from a motor learning and physical exercise perspective. Nevertheless, given that our results showed both immediate (upon the end of treatment), and long-term retention (3&#x02009;months following cessation of treatment) of gait improvement, we may suppose that these benefits can be explained with a neuroplasticity process induced by goal-based exercises (<xref rid="B63" ref-type="bibr">63</xref>). As reported in previous studies (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>), goal-based exercise can promote neuroplasticity effects, which have been demonstrated in several neurological conditions, and also in PD, through changes in cortical excitability and cortical representation. Recently, using fMRI, Agosta et al. (<xref rid="B53" ref-type="bibr">53</xref>) demonstrated AO-related performance enhancement in patients with PD and FoG was possible with an intensive 4-week training program (12 sessions) and was associated with an increased activation of motor cortical areas and fronto parietal regions of the MNS.</p></sec><sec id="S5"><title>Ethics Statement</title><p>This study was carried out in accordance with the recommendations of the &#x0201c;Comitato Etico Regionale Unico&#x0201d; guidelines, with written informed consent from all subjects. All subjects gave written informed consent in accordance with the Declaration of Helsinki. The protocol was approved by the Institutional Ethics Committee (Comitato Etico Regionale Unico&#x02014;Friuli Venezia Giulia. Protocol no. 4456&#x02014;05.02.2015). Patients who agreed to participate always signed a written informed consent and they were able to leave the experiment at any moment, with no additional explanations. The study has been registered at <uri xlink:type="simple" xlink:href="http://Clinicaltrials.gov">http://Clinicaltrials.gov</uri>, NCT03249155.</p></sec><sec id="S6"><title>Author Contributions</title><p>Conception, and design of the research project: SM and PB. Organization of the research project: SM, PB, and PM. Execution of the research project: SM, LP, MC, BK, GF, and PB. Treatment of the patients: SM and LP. Statistical analysis and interpretation of data; writing of the manuscript first draft: SM, MG, and PB. Manuscript review and critique: SM, MG, LP, MC, BK, PM, and PB.</p></sec><sec id="S7"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>The authors wish to thank the patients of the Neurology Clinic&#x02014;Cattinara Hospital (Trieste) for being so generous with their time and efforts.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was not supported by any third party funding or research grant.</p></fn></fn-group><sec id="S8" sec-type="supplementary-material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at <uri xlink:type="simple" xlink:href="http://www.frontiersin.org/articles/10.3389/fneur.2017.00723/full#supplementary-material">http://www.frontiersin.org/articles/10.3389/fneur.2017.00723/full#supplementary-material</uri>.</p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="Table_1.DOCX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="SM2"><media xlink:href="Data_Sheet_1.ZIP"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname><given-names>Y</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>ML</given-names></name><name><surname>Bohnen</surname><given-names>NI</given-names></name><name><surname>Dayalu</surname><given-names>P</given-names></name><name><surname>Seidler</surname><given-names>RD</given-names></name></person-group>. <article-title><sc>l</sc>-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson&#x02019;s disease</article-title>. <source>Behav Brain Res</source> (<year>2012</year>) <volume>230</volume>:<fpage>116</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2012.02.006</pub-id><?supplied-pmid 22343069?><pub-id pub-id-type="pmid">22343069</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruitenberg</surname><given-names>MFL</given-names></name><name><surname>Duthoo</surname><given-names>W</given-names></name><name><surname>Santens</surname><given-names>P</given-names></name><name><surname>Seidler</surname><given-names>RD</given-names></name><name><surname>Notebaert</surname><given-names>W</given-names></name><name><surname>Abrahamse</surname><given-names>EL</given-names></name></person-group>. <article-title>Sequence learning in Parkinson&#x02019;s disease: focusing on action dynamics and the role of dopaminergic medication</article-title>. <source>Neuropsychologia</source> (<year>2016</year>) <volume>93</volume>(<issue>Pt A</issue>):<fpage>30</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2016.09.027</pub-id><?supplied-pmid 27702597?><pub-id pub-id-type="pmid">27702597</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cools</surname><given-names>R</given-names></name><name><surname>Barker</surname><given-names>RA</given-names></name><name><surname>Sahakian</surname><given-names>BJ</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name></person-group>. <article-title>Enhanced or impaired cognitive function in Parkinson&#x02019;s disease as a function of dopaminergic medication and task demands</article-title>. <source>Cereb Cortex</source> (<year>2001</year>) <volume>11</volume>(<issue>12</issue>):<fpage>1136</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1093/cercor/11.12.1136</pub-id><?supplied-pmid 11709484?><pub-id pub-id-type="pmid">11709484</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duthoo</surname><given-names>W</given-names></name><name><surname>Braem</surname><given-names>S</given-names></name><name><surname>Houtman</surname><given-names>F</given-names></name><name><surname>Schouppe</surname><given-names>N</given-names></name><name><surname>Santens</surname><given-names>P</given-names></name><name><surname>Notebaert</surname><given-names>W</given-names></name></person-group>. <article-title>Dopaminergic medication counteracts conflict adaptation in patients with Parkinson&#x02019;s disease</article-title>. <source>Neuropsychology</source> (<year>2013</year>) <volume>27</volume>(<issue>5</issue>):<fpage>556</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1037/a0033377</pub-id><?supplied-pmid 23815093?><pub-id pub-id-type="pmid">23815093</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redgrave</surname><given-names>P</given-names></name><name><surname>Rodriguez</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>Y</given-names></name><name><surname>Rodriguez-Oroz</surname><given-names>MC</given-names></name><name><surname>Lehericy</surname><given-names>S</given-names></name><name><surname>Bergman</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Goal-directed and habitual control in the basal ganglia: implications for Parkinson&#x02019;s disease</article-title>. <source>Nat Rev Neurosci</source> (<year>2010</year>) <volume>11</volume>(<issue>11</issue>):<fpage>760</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1038/nrn2915</pub-id><?supplied-pmid 20944662?><pub-id pub-id-type="pmid">20944662</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandenbossche</surname><given-names>J</given-names></name><name><surname>Deroost</surname><given-names>N</given-names></name><name><surname>Soetens</surname><given-names>E</given-names></name><name><surname>Coomans</surname><given-names>D</given-names></name><name><surname>Spildooren</surname><given-names>J</given-names></name><name><surname>Vercruysse</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Impaired implicit sequence learning in Parkinson&#x02019;s disease patients with freezing of gait</article-title>. <source>Neuropsychology</source> (<year>2013</year>) <volume>27</volume>(<issue>1</issue>):<fpage>28</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1037/a0031278</pub-id><?supplied-pmid 23356594?><pub-id pub-id-type="pmid">23356594</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginis</surname><given-names>P</given-names></name><name><surname>Nackaerts</surname><given-names>E</given-names></name><name><surname>Nieuwboer</surname><given-names>A</given-names></name><name><surname>Heremans</surname><given-names>E</given-names></name></person-group>. <article-title>Cueing for people with Parkinson&#x02019;s disease with freezing of gait: a narrative review of the state-of-the-art and novel perspectives</article-title>. <source>Ann Phys Rehabil Med</source> (<year>2017</year>).<pub-id pub-id-type="doi">10.1016/j.rehab.2017.08.002</pub-id><?supplied-pmid 28890341?><pub-id pub-id-type="pmid">28890341</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patla</surname><given-names>AE</given-names></name><name><surname>Vickers</surname><given-names>JN</given-names></name></person-group>. <article-title>Where and when do we look as we approach and step over an obstacle in the travel path?</article-title>
<source>Neuroreport</source> (<year>1997</year>) <volume>8</volume>(<issue>17</issue>):<fpage>3661</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1097/00001756-199712010-00002</pub-id><?supplied-pmid 9427347?><pub-id pub-id-type="pmid">9427347</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>WR</given-names></name><name><surname>Shreve</surname><given-names>L</given-names></name><name><surname>Quinn</surname><given-names>EJ</given-names></name><name><surname>Craig</surname><given-names>C</given-names></name><name><surname>Bronte-Stewart</surname><given-names>H</given-names></name></person-group>
<article-title>Auditory cueing in Parkinson&#x02019;s patients with freezing of gait. What matters most_action-relevance or cue-continuity?</article-title>
<source>Neuropsychologia</source> (<year>2016</year>) <volume>87</volume>:<fpage>54</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2016.04.034</pub-id><pub-id pub-id-type="pmid">27163397</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefan</surname><given-names>K</given-names></name><name><surname>Cohen</surname><given-names>LG</given-names></name><name><surname>Duque</surname><given-names>J</given-names></name><name><surname>Mazzocchio</surname><given-names>R</given-names></name><name><surname>Celnik</surname><given-names>P</given-names></name><name><surname>Sawaki</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Formation of a motor memory by action observation</article-title>. <source>J Neurosci</source> (<year>2005</year>) <volume>25</volume>(<issue>41</issue>):<fpage>9339</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2282-05.2005</pub-id><?supplied-pmid 16221842?><pub-id pub-id-type="pmid">16221842</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatti</surname><given-names>R</given-names></name><name><surname>Tettamanti</surname><given-names>A</given-names></name><name><surname>Gough</surname><given-names>PM</given-names></name><name><surname>Riboldi</surname><given-names>E</given-names></name><name><surname>Marinoni</surname><given-names>L</given-names></name><name><surname>Buccino</surname><given-names>G</given-names></name></person-group>. <article-title>Action observation versus motor imagery in learning a complex motor task: a short review of literature and a kinematics study</article-title>. <source>Neurosci Lett</source> (<year>2013</year>) <volume>540</volume>:<fpage>37</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1016/j.neulet.2012.11.039</pub-id><?supplied-pmid 23206748?><pub-id pub-id-type="pmid">23206748</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbruzzese</surname><given-names>G</given-names></name><name><surname>Avanzino</surname><given-names>L</given-names></name><name><surname>Marchese</surname><given-names>R</given-names></name><name><surname>Pelosin</surname><given-names>E</given-names></name></person-group>. <article-title>Action observation and motor imagery: innovative cognitive tools in the rehabilitation of Parkinson&#x02019;s disease</article-title>. <source>Parkinsons Dis</source> (<year>2015</year>) <volume>2015</volume>:<fpage>124214</fpage>.<pub-id pub-id-type="doi">10.1155/2015/124214</pub-id><?supplied-pmid 26495150?><pub-id pub-id-type="pmid">26495150</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shams</surname><given-names>L</given-names></name><name><surname>Seitz</surname><given-names>AR</given-names></name></person-group>. <article-title>Benefits of multisensory learning</article-title>. <source>Trends Cogn Sci</source> (<year>2008</year>) <volume>12</volume>(<issue>11</issue>):<fpage>411</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.tics.2008.07.006</pub-id><?supplied-pmid 18805039?><pub-id pub-id-type="pmid">18805039</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidsdottir</surname><given-names>S</given-names></name><name><surname>Cronin-Golomb</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name></person-group>. <article-title>Visual and spatial symptoms in Parkinson&#x02019;s disease</article-title>. <source>Vision Res</source> (<year>2005</year>) <volume>45</volume>(<issue>10</issue>):<fpage>1285</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1016/j.visres.2004.11.006</pub-id><?supplied-pmid 15733961?><pub-id pub-id-type="pmid">15733961</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>S</given-names></name><name><surname>Murray</surname><given-names>MM</given-names></name></person-group>. <article-title>The role of multisensory memories in unisensory object discrimination</article-title>. <source>Brain Res Cogn Brain Res</source> (<year>2005</year>) <volume>24</volume>(<issue>2</issue>):<fpage>326</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.cogbrainres.2005.02.005</pub-id><?supplied-pmid 15993770?><pub-id pub-id-type="pmid">15993770</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Von Kriegstein</surname><given-names>K</given-names></name><name><surname>Giraud</surname><given-names>AL</given-names></name></person-group>. <article-title>Implicit multisensory associations influence voice recognition</article-title>. <source>PLoS Biol</source> (<year>2006</year>) <volume>4</volume>(<issue>10</issue>):<fpage>e326</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pbio.0040326</pub-id><?supplied-pmid 17002519?><pub-id pub-id-type="pmid">17002519</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>G</given-names></name><name><surname>Mohammadi</surname><given-names>B</given-names></name><name><surname>Hammer</surname><given-names>A</given-names></name><name><surname>Heldmann</surname><given-names>M</given-names></name><name><surname>Samii</surname><given-names>A</given-names></name><name><surname>M&#x000fc;nte</surname><given-names>TF</given-names></name><etal/></person-group>
<article-title>Observation of sonified movements engages a basal ganglia frontocortical network</article-title>. <source>BMC Neurosci</source> (<year>2013</year>) <volume>14</volume>(<issue>1</issue>):<fpage>32</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2202-14-32</pub-id><?supplied-pmid 23496827?><pub-id pub-id-type="pmid">23496827</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>RS</given-names></name><name><surname>Seitz</surname><given-names>AR</given-names></name><name><surname>Shams</surname><given-names>L</given-names></name></person-group>. <article-title>Benefits of stimulus congruency for multisensory facilitation of visual learning</article-title>. <source>PLoS One</source> (<year>2008</year>) <volume>3</volume>(<issue>1</issue>):<fpage>e1532</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0001532</pub-id><?supplied-pmid 18231612?><pub-id pub-id-type="pmid">18231612</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>AE</given-names></name><name><surname>Barakat</surname><given-names>BK</given-names></name><name><surname>Jimenez</surname><given-names>LO</given-names></name><name><surname>Shams</surname><given-names>L</given-names></name></person-group>
<article-title>Multisensory congruency enhances explicit awareness in a sequence learning task</article-title>. <source>Multisensor Res</source> (<year>2017</year>) <volume>30</volume>(<issue>7&#x02013;8</issue>):<fpage>681</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1163/22134808-00002587</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigrist</surname><given-names>R</given-names></name><name><surname>Rauter</surname><given-names>G</given-names></name><name><surname>Riener</surname><given-names>R</given-names></name><name><surname>Wolf</surname><given-names>P</given-names></name></person-group>. <article-title>Augmented visual, auditory, haptic, and multimodal feedback in motor learning: a review</article-title>. <source>Psychon Bull Rev</source> (<year>2013</year>) <volume>20</volume>(<issue>1</issue>):<fpage>21</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.3758/s13423-012-0333-8</pub-id><?supplied-pmid 23132605?><pub-id pub-id-type="pmid">23132605</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodger</surname><given-names>MWM</given-names></name><name><surname>Young</surname><given-names>WR</given-names></name><name><surname>Craig</surname><given-names>CM</given-names></name></person-group>. <article-title>Synthesis of walking sounds for alleviating gait disturbances in Parkinson&#x02019;s disease</article-title>. <source>IEEE Trans Neural Syst Rehabil Eng</source> (<year>2014</year>) <volume>22</volume>(<issue>3</issue>):<fpage>543</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1109/TNSRE.2013.2285410</pub-id><?supplied-pmid 24235275?><pub-id pub-id-type="pmid">24235275</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Effenberg</surname><given-names>AO</given-names></name></person-group>
<article-title>Movement sonification: effects on perception and action</article-title>. <source>IEEE Multimedia</source> (<year>2005</year>) <volume>12</volume>(<issue>2</issue>):<fpage>53</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1109/MMUL.2005.31</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>AJ</given-names></name><name><surname>Daniel</surname><given-names>SE</given-names></name><name><surname>Kilford</surname><given-names>L</given-names></name><name><surname>Lees</surname><given-names>AJ</given-names></name></person-group>. <article-title>Accuracy of clinical diagnosis of idiopathic Parkinson&#x02019;s disease: a clinico-pathological study of 100 cases</article-title>. <source>J Neurol Neurosurg Psychiatry</source> (<year>1992</year>) <volume>55</volume>(<issue>3</issue>):<fpage>181</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1136/jnnp.55.3.181</pub-id><?supplied-pmid 1564476?><pub-id pub-id-type="pmid">1564476</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieuwboer</surname><given-names>A</given-names></name><name><surname>Rochester</surname><given-names>L</given-names></name><name><surname>Herman</surname><given-names>T</given-names></name><name><surname>Vandenberghe</surname><given-names>W</given-names></name><name><surname>Emil</surname><given-names>GE</given-names></name><name><surname>Thomaes</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson&#x02019;s disease and their carers</article-title>. <source>Gait Posture</source> (<year>2009</year>) <volume>30</volume>(<issue>4</issue>):<fpage>459</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1016/j.gaitpost.2009.07.108</pub-id><pub-id pub-id-type="pmid">19660949</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goetz</surname><given-names>CG</given-names></name><name><surname>Poewe</surname><given-names>W</given-names></name><name><surname>Rascol</surname><given-names>O</given-names></name><name><surname>Sampaio</surname><given-names>C</given-names></name><name><surname>Stebbins</surname><given-names>GT</given-names></name><name><surname>Counsell</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations</article-title>. <source>Mov Disord</source> (<year>2004</year>) <volume>19</volume>:<fpage>1020</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1002/mds.20213</pub-id><pub-id pub-id-type="pmid">15372591</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name><name><surname>Steer</surname><given-names>RA</given-names></name><name><surname>Brown</surname><given-names>GK</given-names></name></person-group>
<source>Beck Depression Inventory: Manual BDI-II</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Psychological Corporation</publisher-name> (<year>1996</year>).</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arevalo-Rodriguez</surname><given-names>I</given-names></name><name><surname>Smailagic</surname><given-names>N</given-names></name><name><surname>Roqu&#x000e9;</surname><given-names>I</given-names></name><name><surname>Figuls</surname><given-names>M</given-names></name><name><surname>Ciapponi</surname><given-names>A</given-names></name><name><surname>Sanchez-Perez</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Mini-Mental State Examination (MMSE) for the detection of Alzheimer&#x02019;s disease and other dementias in people with mild cognitive impairment (MCI)</article-title>. <source>Cochrane Database Syst Rev</source> (<year>2015</year>) <volume>25</volume>(<issue>3</issue>):<fpage>CD010783</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD010783.pub2</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bandura</surname><given-names>A</given-names></name></person-group>
<source>Social Learning Theory</source>. <publisher-loc>Toronto, Canada</publisher-loc>: <publisher-name>Prentice-Hall</publisher-name> (<year>1977</year>).</mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelosin</surname><given-names>E</given-names></name><name><surname>Avanzino</surname><given-names>L</given-names></name><name><surname>Bove</surname><given-names>M</given-names></name><name><surname>Stramesi</surname><given-names>P</given-names></name><name><surname>Nieuwboer</surname><given-names>A</given-names></name><name><surname>Abbruzzese</surname><given-names>G</given-names></name></person-group>
<article-title>Action observation improves freezing of gait in patients with Parkinson&#x02019;s disease</article-title>. <source>Neurorehabil Neural Repair</source> (<year>2010</year>) <volume>24</volume>(<issue>8</issue>):<fpage>746</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1177/1545968310368685</pub-id><pub-id pub-id-type="pmid">20453155</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peto</surname><given-names>V</given-names></name><name><surname>Jenkinson</surname><given-names>C</given-names></name><name><surname>Fitzpatrick</surname><given-names>R</given-names></name></person-group>
<article-title>PDQ-39: a review of the development, validation and application of a Parkinson&#x02019;s disease quality of life questionnaire and its associated measures</article-title>. <source>J Neurol</source> (<year>1998</year>) <volume>245</volume>(<issue>1</issue>):<fpage>S10</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1007/PL00007730</pub-id><pub-id pub-id-type="pmid">9617716</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keus</surname><given-names>SHJ</given-names></name><name><surname>Nieuwboer</surname><given-names>A</given-names></name><name><surname>Bloem</surname><given-names>BR</given-names></name><name><surname>Borm</surname><given-names>GF</given-names></name><name><surname>Munneke</surname><given-names>M</given-names></name></person-group>. <article-title>Clinimetric analyses of the Modified Parkinson Activity Scale</article-title>. <source>Parkinsonism Relat Disord</source> (<year>2009</year>) <volume>15</volume>(<issue>4</issue>):<fpage>263</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.parkreldis.2008.06.003</pub-id><?supplied-pmid 18691929?><pub-id pub-id-type="pmid">18691929</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Podsiadlo</surname><given-names>D</given-names></name><name><surname>Richardson</surname><given-names>S</given-names></name></person-group>
<article-title>The timed &#x0201c;Up &#x00026; Go&#x0201d;: a test of basic functional mobility for frail elderly persons</article-title>. <source>J Am Geriatr Soc</source> (<year>1991</year>) <volume>39</volume>(<issue>2</issue>):<fpage>142</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.1532-5415.1991.tb01616.x</pub-id><pub-id pub-id-type="pmid">1991946</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falvo</surname><given-names>MJ</given-names></name><name><surname>Earhart</surname><given-names>GM</given-names></name></person-group>. <article-title>Six-minute walk distance in persons with Parkinson disease: a hierarchical regression model</article-title>. <source>Arch Phys Med Rehabil</source> (<year>2009</year>) <volume>90</volume>(<issue>6</issue>):<fpage>1004</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.apmr.2008.12.018</pub-id><?supplied-pmid 19480877?><pub-id pub-id-type="pmid">19480877</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>KO</given-names></name><name><surname>Wood-Dauphinee</surname><given-names>SL</given-names></name><name><surname>Williams</surname><given-names>JI</given-names></name><name><surname>Maki</surname><given-names>B</given-names></name></person-group>. <article-title>Measuring balance in the elderly: validation of an instrument</article-title>. <source>Can J Public Health</source> (<year>1992</year>) <volume>83</volume>:<fpage>S7</fpage>&#x02013;<lpage>11</lpage>.<?supplied-pmid 1468055?><pub-id pub-id-type="pmid">1468055</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasreddine</surname><given-names>ZS</given-names></name><name><surname>Phillips</surname><given-names>NA</given-names></name><name><surname>B&#x000e9;dirian</surname><given-names>V</given-names></name><name><surname>Charbonneau</surname><given-names>S</given-names></name><name><surname>Whitehead</surname><given-names>V</given-names></name><name><surname>Collin</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment</article-title>. <source>J Am Geriatr Soc</source> (<year>2005</year>) <volume>53</volume>(<issue>4</issue>):<fpage>695</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.1532-5415.2005.53221.x</pub-id><?supplied-pmid 15817019?><pub-id pub-id-type="pmid">15817019</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orsini</surname><given-names>A</given-names></name><name><surname>Grossi</surname><given-names>D</given-names></name><name><surname>Capitani</surname><given-names>E</given-names></name><name><surname>Laiacona</surname><given-names>M</given-names></name><name><surname>Papagno</surname><given-names>C</given-names></name><name><surname>Vallar</surname><given-names>G</given-names></name></person-group>. <article-title>Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children</article-title>. <source>Ital J Neurol Sci</source> (<year>1987</year>) <volume>8</volume>(<issue>6</issue>):<fpage>537</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1007/BF02333660</pub-id><?supplied-pmid 3429213?><pub-id pub-id-type="pmid">3429213</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Renzi</surname><given-names>E</given-names></name><name><surname>Nichelli</surname><given-names>P</given-names></name></person-group>. <article-title>Verbal and non-verbal short-term memory impairment following hemispheric damage</article-title>. <source>Cortex</source> (<year>1975</year>) <volume>11</volume>(<issue>4</issue>):<fpage>341</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1016/S0010-9452(75)80026-8</pub-id><?supplied-pmid 1222578?><pub-id pub-id-type="pmid">1222578</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlesimo</surname><given-names>GA</given-names></name><name><surname>Buccione</surname><given-names>I</given-names></name><name><surname>Fadda</surname><given-names>L</given-names></name></person-group>
<article-title>Normative data of two memory tasks: short-story recall and Rey&#x02019;s figure</article-title>. <source>Nuova Rivista Di Neurologia</source> (<year>2002</year>) <volume>12</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>13</lpage>.</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Della Sala</surname><given-names>S</given-names></name><name><surname>Laiacona</surname><given-names>M</given-names></name><name><surname>Spinnler</surname><given-names>H</given-names></name><name><surname>Ubezio</surname><given-names>C</given-names></name></person-group>. <article-title>A cancellation test: its reliability in assessing attentional deficits in Alzheimer&#x02019;s disease</article-title>. <source>Psychol Med</source> (<year>1992</year>) <volume>22</volume>(<issue>4</issue>):<fpage>885</fpage>&#x02013;<lpage>901</lpage>.<pub-id pub-id-type="doi">10.1017/S0033291700038460</pub-id><?supplied-pmid 1488486?><pub-id pub-id-type="pmid">1488486</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbarotto</surname><given-names>R</given-names></name><name><surname>Laiacona</surname><given-names>M</given-names></name><name><surname>Frosio</surname><given-names>R</given-names></name><name><surname>Vecchio</surname><given-names>M</given-names></name><name><surname>Farinato</surname><given-names>A</given-names></name><name><surname>Capitani</surname><given-names>E</given-names></name></person-group>. <article-title>A normative study on visual reaction times and two Stroop colour-word tests</article-title>. <source>Ital J Neurol Sci</source> (<year>1998</year>) <volume>19</volume>(<issue>3</issue>):<fpage>161</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1007/BF00831566</pub-id><?supplied-pmid 10933471?><pub-id pub-id-type="pmid">10933471</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giovagnoli</surname><given-names>AR</given-names></name><name><surname>Del Pesce</surname><given-names>M</given-names></name><name><surname>Mascheroni</surname><given-names>S</given-names></name><name><surname>Simoncelli</surname><given-names>M</given-names></name><name><surname>Laiacona</surname><given-names>M</given-names></name><name><surname>Capitani</surname><given-names>E</given-names></name></person-group>. <article-title>Trail making test: normative values from 287 normal adult controls</article-title>. <source>Ital J Neurol Sci</source> (<year>1996</year>) <volume>17</volume>(<issue>4</issue>):<fpage>305</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1007/BF01997792</pub-id><?supplied-pmid 8915764?><pub-id pub-id-type="pmid">8915764</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iavarone</surname><given-names>A</given-names></name><name><surname>Ronga</surname><given-names>B</given-names></name><name><surname>Pellegrino</surname><given-names>L</given-names></name><name><surname>Lor&#x000e9;</surname><given-names>E</given-names></name><name><surname>Vitaliano</surname><given-names>S</given-names></name><name><surname>Galeone</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>The Frontal Assessment Battery (FAB): normative data from an Italian sample and performances of patients with Alzheimer&#x02019;s disease and frontotemporal dementia</article-title>. <source>Funct Neurol</source> (<year>2004</year>) <volume>19</volume>(<issue>3</issue>):<fpage>191</fpage>&#x02013;<lpage>5</lpage>.<?supplied-pmid 15595714?><pub-id pub-id-type="pmid">15595714</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krikorian</surname><given-names>R</given-names></name><name><surname>Bartok</surname><given-names>J</given-names></name><name><surname>Gay</surname><given-names>N</given-names></name></person-group>. <article-title>Tower of London procedure: a standard method and developmental data</article-title>. <source>J Clin Exp Neuropsychol</source> (<year>1994</year>) <volume>16</volume>(<issue>6</issue>):<fpage>840</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1080/01688639408402697</pub-id><?supplied-pmid 7890819?><pub-id pub-id-type="pmid">7890819</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Belacchi</surname><given-names>C</given-names></name><name><surname>Scalisi</surname><given-names>TG</given-names></name><name><surname>Cannoni</surname><given-names>E</given-names></name><name><surname>Cornoldi</surname><given-names>C</given-names></name></person-group>
<source>CPM-Coloured Progressive Matrices. Standardizzazione Italiana</source>. <publisher-loc>Firenze</publisher-loc>: <publisher-name>Giunti &#x02013; Organizzazioni Speciali</publisher-name> (<year>2008</year>).</mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Puckette</surname><given-names>M</given-names></name></person-group>
<source>Pd Documentation</source>. (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="http://msp.ucsd.edu/Pd_documentation/">http://msp.ucsd.edu/Pd_documentation/</uri></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Henkelmann</surname><given-names>C</given-names></name></person-group>
<source>Improving the Aesthetic Quality of Realtime Motion Data Sonification (No. CG-2007-4)</source>. <publisher-loc>Bonn, Germany</publisher-loc>: <publisher-name>Universit&#x000e4;t Bonn</publisher-name> (<year>2007</year>).</mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Henkelmann</surname><given-names>C</given-names></name><name><surname>Zinke</surname><given-names>A</given-names></name><name><surname>Weber</surname><given-names>A</given-names></name></person-group>
<article-title>Towards aesthetic realtime sonification of motion data</article-title>. <source>Presented at the 4. Workshop Virtuelle Realit&#x000e4;t und Augmented Reality der GI-Fachgruppe VR/AR 2007</source>. <publisher-loc>Bonn, Germany</publisher-loc>: <publisher-name>Weimar</publisher-name> (<year>2007</year>).</mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olejnik</surname><given-names>S</given-names></name><name><surname>Algina</surname><given-names>J</given-names></name></person-group>. <article-title>Generalized eta and omega squared statistics: measures of effect size for some common research designs</article-title>. <source>Psychol Methods</source> (<year>2003</year>) <volume>8</volume>(<issue>4</issue>):<fpage>434</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1037/1082-989X.8.4.434</pub-id><?supplied-pmid 14664681?><pub-id pub-id-type="pmid">14664681</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakeman</surname><given-names>R</given-names></name></person-group>. <article-title>Recommended effect size statistics for repeated measures designs</article-title>. <source>Behav Res Methods</source> (<year>2005</year>) <volume>37</volume>(<issue>3</issue>):<fpage>379</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.3758/BF03192707</pub-id><?supplied-pmid 16405133?><pub-id pub-id-type="pmid">16405133</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreau</surname><given-names>D</given-names></name><name><surname>Kirk</surname><given-names>IJ</given-names></name><name><surname>Waldie</surname><given-names>KE</given-names></name></person-group>. <article-title>Seven pervasive statistical flaws in cognitive training interventions</article-title>. <source>Front Hum Neurosci</source> (<year>2016</year>) <volume>10</volume>:<fpage>153</fpage>.<pub-id pub-id-type="doi">10.3389/fnhum.2016.00153</pub-id><?supplied-pmid 27148010?><pub-id pub-id-type="pmid">27148010</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Macmillan</surname><given-names>NA</given-names></name><name><surname>Creelman</surname><given-names>CD</given-names></name></person-group>
<source>Detection Theory: A User&#x02019;s Guide</source>. <publisher-loc>Mahwah, New Jersey</publisher-loc>: <publisher-name>Laurence Erlbaum Associates</publisher-name> (<year>2005</year>).</mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="book"><collab>R Development Core Team</collab>. <source>R: A Language and Environment for Statistical Computing</source>. <publisher-name>R Foundation for Statistical Computing</publisher-name> (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.R-project.org">http://www.R-project.org</uri></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agosta</surname><given-names>F</given-names></name><name><surname>Gatti</surname><given-names>R</given-names></name><name><surname>Sarasso</surname><given-names>E</given-names></name><name><surname>Volont&#x000e9;</surname><given-names>MA</given-names></name><name><surname>Canu</surname><given-names>E</given-names></name><name><surname>Meani</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Brain plasticity in Parkinson&#x02019;s disease with freezing of gait induced by action observation training</article-title>. <source>J Neurol</source> (<year>2017</year>) <volume>264</volume>(<issue>1</issue>):<fpage>88</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="doi">10.1007/s00415-016-8309-7</pub-id><?supplied-pmid 27778161?><pub-id pub-id-type="pmid">27778161</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieuwboer</surname><given-names>A</given-names></name><name><surname>Rochester</surname><given-names>L</given-names></name><name><surname>M&#x000fc;ncks</surname><given-names>L</given-names></name><name><surname>Swinnen</surname><given-names>SP</given-names></name></person-group>
<article-title>Motor learning in Parkinson&#x02019;s disease: limitations and potential for rehabilitation</article-title>. <source>Parkinsonism Relat Disord</source> (<year>2009</year>) <volume>15</volume>(<issue>Suppl 3</issue>):<fpage>S53</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/S1353-8020(09)70781-3</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Amundsen Huffmaster</surname><given-names>SL</given-names></name><name><surname>Tuite</surname><given-names>PJ</given-names></name><name><surname>Vachon</surname><given-names>JM</given-names></name><name><surname>MacKinnon</surname><given-names>CD</given-names></name></person-group>. <article-title>Effect of cue timing and modality on gait initiation in Parkinson disease with freezing of gait</article-title>. <source>Arch Phys Med Rehabil</source> (<year>2017</year>) <volume>98</volume>(<issue>7</issue>):<fpage>1291</fpage>&#x02013;<lpage>9.e1</lpage>.<pub-id pub-id-type="doi">10.1016/j.apmr.2017.01.009</pub-id><?supplied-pmid 28167093?><pub-id pub-id-type="pmid">28167093</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidler</surname><given-names>RD</given-names></name><name><surname>Bernard</surname><given-names>JA</given-names></name><name><surname>Burutolu</surname><given-names>TB</given-names></name><name><surname>Fling</surname><given-names>BW</given-names></name><name><surname>Gordon</surname><given-names>MT</given-names></name><name><surname>Gwin</surname><given-names>JT</given-names></name><etal/></person-group>
<article-title>Motor control and aging: links to age-related brain structural, functional, and biochemical effects</article-title>. <source>Neurosci Biobehav Rev</source> (<year>2010</year>) <volume>34</volume>(<issue>5</issue>):<fpage>721</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1016/j.neubiorev.2009.10.005</pub-id><?supplied-pmid 19850077?><pub-id pub-id-type="pmid">19850077</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunting-Perry</surname><given-names>L</given-names></name><name><surname>Spindler</surname><given-names>M</given-names></name><name><surname>Robinson</surname><given-names>KM</given-names></name><name><surname>Noorigian</surname><given-names>J</given-names></name><name><surname>Cianci</surname><given-names>HJ</given-names></name><name><surname>Duda</surname><given-names>JE</given-names></name></person-group>. <article-title>Laser light visual cueing for freezing of gait in Parkinson disease: a pilot study with male participants</article-title>. <source>J Rehabil Res Dev</source> (<year>2013</year>) <volume>50</volume>(<issue>2</issue>):<fpage>223</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1682/JRRD.2011.12.0255</pub-id><?supplied-pmid 23761003?><pub-id pub-id-type="pmid">23761003</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname><given-names>C</given-names></name></person-group>
<article-title>Audiovisual multisensory integration</article-title>. <source>Acoust Sci Technol</source> (<year>2007</year>) <volume>28</volume>(<issue>2</issue>):<fpage>61</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1250/ast.28.61</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vatakis</surname><given-names>A</given-names></name><name><surname>Spence</surname><given-names>C</given-names></name></person-group>
<article-title>Crossmodal binding: evaluating the &#x0201c;unity assumption&#x0201d; using audiovisual speech stimuli</article-title>. <source>Percept Psychophys</source> (<year>2007</year>) <volume>69</volume>(<issue>5</issue>):<fpage>744</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.3758/BF03193776</pub-id><pub-id pub-id-type="pmid">17929697</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolpert</surname><given-names>DM</given-names></name><name><surname>Diedrichsen</surname><given-names>J</given-names></name><name><surname>Flanagan</surname><given-names>JR</given-names></name></person-group>
<article-title>Principles of sensorimotor learning</article-title>. <source>Nat Rev Neurosci</source> (<year>2011</year>) <volume>12</volume>:<fpage>739</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1038/nrn3112</pub-id><pub-id pub-id-type="pmid">22033537</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunetti</surname><given-names>R</given-names></name><name><surname>Indraccolo</surname><given-names>A</given-names></name><name><surname>Mastroberardino</surname><given-names>S</given-names></name><name><surname>Spence</surname><given-names>C</given-names></name><name><surname>Santangelo</surname><given-names>V</given-names></name></person-group>. <article-title>The impact of cross-modal correspondences on working memory performance</article-title>. <source>J Exp Psychol Hum Percept Perform</source> (<year>2017</year>) <volume>43</volume>(<issue>4</issue>):<fpage>819</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1037/xhp0000348</pub-id><?supplied-pmid 28345948?><pub-id pub-id-type="pmid">28345948</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JM</given-names></name><name><surname>Shine</surname><given-names>JM</given-names></name><name><surname>Walton</surname><given-names>CC</given-names></name><name><surname>Gilat</surname><given-names>M</given-names></name><name><surname>Kamsma</surname><given-names>YPT</given-names></name><name><surname>Naismith</surname><given-names>SL</given-names></name><etal/></person-group>
<article-title>Early phenotypic differences between Parkinson&#x02019;s disease patients with and without freezing of gait</article-title>. <source>Parkinsonism Relat Disord</source> (<year>2014</year>) <volume>20</volume>(<issue>6</issue>):<fpage>604</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.parkreldis.2014.02.028</pub-id><?supplied-pmid 24679901?><pub-id pub-id-type="pmid">24679901</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petzinger</surname><given-names>GM</given-names></name><name><surname>Fisher</surname><given-names>BE</given-names></name><name><surname>McEwen</surname><given-names>S</given-names></name><name><surname>Beeler</surname><given-names>JA</given-names></name><name><surname>Walsh</surname><given-names>JP</given-names></name><name><surname>Jakowec</surname><given-names>MW</given-names></name></person-group>. <article-title>Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson&#x02019;s disease</article-title>. <source>Lancet Neurol</source> (<year>2013</year>) <volume>12</volume>(<issue>7</issue>):<fpage>716</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/S1474-4422(13)70123-6</pub-id><?supplied-pmid 23769598?><pub-id pub-id-type="pmid">23769598</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrester</surname><given-names>LW</given-names></name><name><surname>Hanley</surname><given-names>DF</given-names></name><name><surname>Macko</surname><given-names>RF</given-names></name></person-group>. <article-title>Effects of treadmill exercise on transcranial magnetic stimulation-induced excitability to quadriceps after stroke</article-title>. <source>Arch Phys Med Rehabil</source> (<year>2006</year>) <volume>87</volume>(<issue>2</issue>):<fpage>229</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.apmr.2005.10.016</pub-id><?supplied-pmid 16442977?><pub-id pub-id-type="pmid">16442977</pub-id></mixed-citation></ref></ref-list><app-group><app id="A1"><title>Appendix</title><sec id="S9-1"><title>Exercise 1</title><p>Shifting the body weight in the frontal plane and taking a step&#x02014;Actor stands straight up, with both feet on the floor, shifting the body weight to the right (or to the left), to the left (or to the right), and then raise and move forward the right (or the left) leg and the body to take the first step.</p></sec><sec id="S9-2"><title>Exercise 2</title><p>Shifting the body weight in the sagittal plane and taking a step&#x02014;Actor stands straight up with both feet on the floor. One foot placed in front of the other, with the heel ahead of the other foot&#x02019;s toes. The actor shifts weight from one foot to the other, always keeping the feet on the floor; afterwards he takes a step forward.</p></sec><sec id="S9-3"><title>Exercise 3</title><p>Gait initiation&#x02014;Actor starts to walk with the preferred leg.</p></sec><sec id="S9-4"><title>Exercise 4</title><p>Turning around&#x02014;Actor walks two steps with a straight trajectory, and then made a 180&#x000b0; turn in a narrow quarter (U-turn).</p></sec><sec id="S9-5"><title>Exercise 5</title><p>Stepping over an obstacle&#x02014;Actor walks three steps with a straight trajectory, and then steps over the obstacle (obstacle&#x02019;s height: 10% of patient&#x02019;s height).</p></sec><sec id="S9-6"><title>Exercise 6</title><p>Sit-to-walk&#x02014;Actor is seated on a backless and armless stool (knee angle 100&#x000b0;), and then raises and walks three steps forward.</p></sec><sec id="S9-7"><title>Exercise 7</title><p>Walking straight with long steps&#x02014;Actor walks about 10 long steps with a straight trajectory trying to maintain a steady pace and to take long steps.</p></sec><sec id="S9-8"><title>Exercise 8</title><p>Walking through a doorway&#x02014;Actor walks three steps with a straight trajectory, moves through a real doorway without stopping and then continue to walk two more steps.</p></sec></app></app-group></back></article>